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Gene–environment interaction is the crucial determinant of the 
structural organisation of the brain that eventually will reflect upon the 
optimal functionality. During the early stages of life, the central nervous 
system (CNS) is especially susceptible to environmental stimuli. In 
particular adverse environmental conditions, such as nutritional deficits or 
exposure to toxic agents, have detrimental effects over the normal CNS 
development, contributing to the insurgence of neuropsychiatric disorders 
(Schmechel et al. 2006; Tau et al. 2010; Miodovnik 2011).  
The cumulative impact of technological changes has facilitated an 
increased pollution. In fact a wide range of chemical substances are present 
in the environment, among them, Polybrominated diphenyl ethers (PBDEs) 
are one of concern because of their persistency, bioaccumulation and 
toxicity on the Endocrine and Nervous systems (Darnerud et al. 2001; 
Costa et al. 2007; Talsness 2008). Notable levels of PBDEs have been 
found in human’s blood and breast milk, for what is especially worrying its 
exposure during prenatal and postnatal development (Darnerud et al. 2001; 
Schuhmacher et al. 2009; Vizcaino et al. 2010). Gender, age or genetic 
factors may provide distinct protection or vulnerability to illness or adverse 
conditions. In this sense different polimorphisms of Apolipoprotein E, 
focus of this dissertation, have been related to different risk for metabolic, 
cardiovascular or neurodegenerative disease (Arendt 2001; Hatters et al. 
2006). Being carrier of ApoE4 allele is the major risk for developing 
Alzheimer’s disease, and also increases the risk of neurocognitive damage 
after injury or negative conditions (Grootendorst et al. 2005; van Meer et 
al. 2007; Reitz et al. 2009). We hypothesised that an early exposure to 
BDE-209, a higher brominated PBDE congener which is supposed to be 
less toxic, can induce long-term impairments and interact with ApoE 
genotype, being ApoE4 more vulnerable to the injuries. To test this, mice 
carrying the Human ApoE isoforms – ApoE2, ApoE3 and ApoE4, were 
treated with an acute oral dose of 0, 10 or 30 mg/kg of BDE-209 on 
postnatal day 10, and were assessed for neurobehaviour at three major 
moments in life; development, young adulthood and old age. Additionally, 
myelination pattern during development, and thyroid hormone and BDNF 
levels in adults were also determined. Our findings show that ApoE 
genotype has strong influence in growth and behaviour during late 
development, and throughout life in activity, anxiety and learning 
performance. Mice carrying distinct polimorphisms of ApoE also show 
different levels of BDNF and its receptor TrkB in the hippocampus and 
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different thyroid hormone status. Moreover, BDE-209 exposure is able to 
induce short and long-term effects, but depending on ApoE genotype and 
age. An acute exposure to BDE-209 on postnatal day 10 produces a delay 
in growth, motor and sexual development in ApoE2, likely by the 
interference on myelin compaction which was also altered in these mice. In 
adulthood, postnatal BDE-209 exposure decreases the levels of free 
thyroxin in females, enhances the inherent hypoactivity of ApoE4 and 
worsens good learning scores observed in ApoE3 males. The effects of 
BDE-209 exposure are also evident at old ages. Exposed ApoE3 aged mice 
show increased anxiety levels compared with their control counterparts. 
BDE-209 also impairs learning and memory, especially in ApoE3, at 
advanced ages. The results of this research point that BDE-209 has 
potential neurotoxicity and interacts with genetic factors and age. 
Furthermore, it highlights the importance of longitudinal and multifactorial 
methodology in toxicological surveys in order to detect long term effects 
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SORL1   Sortilin-related Receptor L 
T3  Triiodothyronine 
T4  Thyroxine 
TrKB  Neurotrophic Tyrosine Kinase Receptor 
TSH   Thyroid Stimulating Hormone 
UDGPT   Glucoronosyltransferase 
USA   United States of America 
VLDL   Very Low-density Lipoprotein 
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This dissertation is concerned with the long lasting effects derived 
from perinatal exposure to environmental toxic chemicals. The 
repercussion of early exposures to toxic agents on health in adults and in 
the elderly is difficult to establish from epidemiological studies. That is, the 
time elapsed between the exposure and the effect, the possibility of 
multiple other factors contributing to the related effect, and differences in 
genetic background accounting for individual differences make it 
complicated, especially when the effect is not salient enough. For these 
reasons, experimental approaches to assess long lasting effects derived 
from low or acute exposures are an important tool and an additional source 
of data for risk assessment in humans.  
 
Several studies on Polibrominated Diphenyl Ether (PBDE) toxicity have 
been reported since its introduction as flame retardants and its extensive 
use around the world. The lower brominated forms, penta and octa 
brominated congeners, have shown neurotoxicity and are banned in Europe 
and several states of U.S.A. They are also considered endocrine disrupters 
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as they interfere with the thyroid system, which in turn could be implicated 
in the developmental effects.   
 
The deca-brominated form (BDE-209) is still in use and differs from the 
lower brominated forms in its absorption, which is lower, and its excretion, 
which is higher, showing a short half-life. Its degradation to lower 
brominated forms in the environment due to thermolability and 
photosensitivity and its degradation and debromination inside the body 
after ingestion is an issue of study and debate. In the last years, the 
literature on the neurotoxic effects of the higher brominated compound has 
increased and some discrepancies emerged between studies. The diversity 
of doses, exposure periods, species, strains, time at testing and endpoints 
assessed are beyond these differences between studies. In general term 
studies point to some behavioural effects which increase or are more 
evident with age.  Taking these considerations together, an open question is 
how these perinatal exposures are able to interact with known risk genetic 
factors for aging, cognitive impairment or other pathologies. To asses this, 
we planned a longitudinal study in transgenic ApoE mice carrying the 
human ApoE2,  ApoE3 and ApoE4 polymorphisms characterized for 
presenting different vulnerabilities to metabolic and cardiovascular diseases 
and neurodegeneration. The study was divided in three experimental phases 
to assess the effects of postnatal exposure to BDE-209 during development, 
in 4 months young and in 12 months old transgenic mice. 
Neurodevelopmental landmarks, activity and anxiety, learning and 
memory, thyroid hormones, myelination pattern and levels of BDNF 
neutrophine and its Tirosine Kinase B (TrkB) neurotrophin receptor were 
studied at different point times.   
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2. Motivation 
 
Using a top-down approach, 3 major factors motivate the work described in 
this dissertation: 
 
 The desire to describe longitudinally the degree of severity of 
behavioural alterations derived from the exposure to industrial 
chemical agents present in the environment during development. 
 
 Understanding the genetic risk factors in interplay with toxic agent 
exposure. 
 
 The identification of orderly interaction between age, sex, genetic 
asset and neurotoxic agent exposure and its mechanism of action.  
 
3. Organization of the thesis 
 
 
The dissertation is organized in seven chapters as follows; 
 
 In the first chapter there is an overview on the basic issues 
concerning the Central Nervous System development and plasticity, 
a review of Polibrominated Diphenil Ethers toxicity and on the role 
of Apolipoprotein E in normal and pathological brain function, and 
an outline on the neurobehavioural assessment in rodent animal 
models. 
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 In the second chapter are presented the justification of the study, the 
research hypothesis and the main purpouse and objectives proposed 
to accomplish them.   
 
 In the third chapter there is a detailed description of the experimental 
design and used procedures.  
 
 In the fourth chapter are presented and discussed the results obtained 
in the different experimental phases of the research.   
 
 In the fifth chapter is presented a general discussion on the main 
findings and are posed the future directions for further investigation. 
 
 In the sixth chapter are pointed out the main conclusions derived 
from the research.  
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                                         Approximately 80,000 industrial 
chemicals are reported by regulatory agencies as present in the 
environment, and less than 1% of these substances have been examined for 
its neurotoxicity (Miodovnik 2011). There is evidence that environmental 
toxic exposure during development may affect health of infants and long-
life disabilities. Neurodevelopmental disorders, which include mental 
retardation, dyslexia, autism and attention-deficit and hyperactivity 
disorder (ADHD), affect 13-16% of children (Grandjean et al. 2006; 
Miodovnik 2011; Stein et al. 2011). Chromosome alterations, infections 
and/or drug exposure during pregnancy, or perinatal anoxia are factors that 
can cause neurodevelopmental disorders, but the aetiology of 3% of these 
disorders may be attributed to environmental toxic exposure and another 
25% may result from the interaction of environmental exposure with 
genetic predisposition (Grandjean et al. 2006; Miodovnik 2011). The 
recognition of genes that provides risk factors is the key to understand the 
role of the environment in developmental processes and genotypes that 
give rise to protective or vulnerable phenotypes against disease and toxic 
effects (Schmechel et al. 2006; Lenroot et al. 2011). Genes and 
environment interactions across lifespan are time and space dependent, 
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leading to a great amount of different effects depending on the age at which 
exposure occurs. Along these lines, there is evidence that some chemicals 
induce developmental toxicity at low doses that do not affect adult subjects. 
Frequently, exposure to low doses of those agents do not cause acute 
effects, but induce permanent changes in Central Nervous System (CNS) 
which give rise to subtle neurobehavioral effects, called subclinical 
toxicity.  In addition, minimal lesions or functional alterations of the 
Nervous System (NS) can remain latent until a compensatory capacity of 
the NS decreases, precipitating the appearance of neurological and/or 
psychiatric disorders in adulthood or old age. Regarding that, toxic factors 
can affect normal aging and the onset and progression of 
neurodegeneration (Schmechel et al. 2006). For example, carbon 
monoxide, pesticide and heavy metal exposures have been proposed to 
contribute in developing Parkinson or Alzheimer’s Disease (Grandjean et 
al. 2006; Schmechel et al. 2006). To sum up, toxic exposure during 
development may affect health of children and/or induce diseases long after 
exposure in young or older adults. To establish the causal associations 
between toxic exposure and its effects is challenging because of the high 
variability due to genetic and environmental interactions and variable time 
between exposure to noxious agents and their effects. In this sense, 
experimental studies should allow us to identify the risk factors implicated 
in the appearance of neurological and neuropsychiatric disorders with 
multifactorial etiology. The detection of  hazardous agents and vulnerable 
populations to their toxicity is essential because the effects of 
environmental chemicals entail great personal, social and economic costs  
and may be preventable (Grandjean et al. 2006).  
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1. Development and plasticity of the Central Nervous 
System 
 
The development of the central nervous system depends on multiple 
interactions between its cells, glial and neurons, and the signals they 
receive from each other. Among the many factors involved, a pattern of 
neural activity will be necessary for the establishment of appropriate 
contacts and to modulate the secretion of different intercellular signalling 
molecules such as neurotrophins or neurotransmitters. 
 
The timing of development depends on each species. In rats and mice the 
brain grows rapidly from birth through eleven days and quite slowly 
thereafter. This period of rapid growth is called Brain Growth Spurt (BGS), 
and reaches the maximum peak of growth around postnatal day 10. During 
this period, several processes like axon and dendrites growth, establishment 
of synaptic contacts and differentiation occurs at a maximum rate. These 
processes are mediated by multiple signalling mechanisms and the many 
different molecules such as hormones, neurotrophins or activity dependent 
factors are implicated. Glial cells also play an important role in the 
development and function of CNS. In the last years glial cells alterations 
have been linked to several functional deficits and neurological and 
psychiatric pathologies.  
 
The proper organization of the brain circuitry is essential for a correct 
development of the CNS. Myelination, together with neurogenesis, 
synaptogenesis and synaptic modulation, is a key process involved in 
establishes an effective connectivity. Myelin has a role in the maintenance 
of axons it envolves and allows the rapid conduction of the electrical 
UNIVERSITAT ROVIRA I VIRGILI 
NEUROBEHAVIOURAL EFFECTS ASSOCIATED WITH POSTNATAL EXPOSURE TO DECABROMODIPHENYL ETHER IN APOE2, 
APOE3 AND APOE4 TRANSGENIC MICE 
Ingrid Reverté Soler 
DL:T. 162-2012 
                   Introduction  
    30 
impulses. The myelination of axons starts before birth but is mainly 
developed postnatally, and like in all the processes during development, the 
preservation of the timing at which myelination occurs is critic for an 
optimal function (Tau et al. 2010). Myelin synthesis in the CNS is carried 
out by oligodendrocytes. Myelin organization, conditional upon 
oligodendrocyte maturation, is depending on axon signals, which in turn 
are mediated by growth factors, thyroid hormones, cell adhesion molecules 
and neureregulins among others. The formation of myelin sheath requires 
the coordinated assembly of myelin proteic components, such as myelin 
basic protein (MBP) and  proteolipid protein (Miller 2002). The expression 
of these proteins reaches the maximum peak around postnatal day 20 in 
mice (Jordan et al. 1989).  
 
Both, Thyroid Hormones (TH) and Brain-derived neurotrophic factor 
(BDNF) play an important role in myelination of the CNS (Barres et al. 
1994; Cellerino et al. 1997; Xiao et al. 2009). Levels of Neuron-growth 
factor (NGF), BDNF and Neurotrophin 3 (NT-3) are regulated by thyroid 
hormones at the level of gene expression during developmental stages. In 
addition, BDNF and its receptor tyrosine kinase B (TrkB) genes are also 
expressed in the pituitary (Kononen et al. 1994), so BDNF could regulate 
the production of pituitary hormones, including thyroid stimulating 
hormone (TSH). Thyroid hormones are known to regulate the survival of 
oligodendrocytes and myelination (Barres et al. 1994; Pasquini et al. 1994).  
Mechanisms of action of thyroid hormones in the brain during development 
are mainly mediated by the control of gene expression. The genes affected 
during the postnatal period are not as sensitive to thyroid hormones in 
adults. The most sensitive period of thyroid hormone in the brain is limited 
to the first 2-3 postnatal weeks in rodents, which would correspond to the 
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twentieth week of gestation to 2-3 years after birth in humans. Important 
developmental events occur during this period, such as myelination, 
development of the cerebellum, dentate gyrus, glial cell proliferation, 
differentiation of neurons, synapse formation and axon and dendrite 
sprouting (Watson et al. 2006). Recent investigations have studied myelin 
alterations in relation to both behavioural and cognitive deficits (Kodama et 
al. 2008; Tanaka et al. 2009).  
 
1.2 The role of neurotrophines in the CNS 
 
Neurotrophines and their receptors are a group of molecules involved in 
multiple signalling processes in the brain; they regulate many aspects of 
neural development and plasticity. Four neurotrophins are expressed in 
mammals: NGF, BDNF, neurotrophin-3 (NT-3) and neurotrophin-4 (NT-
4). BDNF is highly expressed in brain of many mammalian species. During 
normal development, BDNF regulates dendritic growth of neurons and 
many growth factors are involved in the proliferation, differentiation, and 
maturation of the oligodendrocytes which are involved in myelination 
(Djalali et al. 2005). In the adult brain, BDNF facilitates long term 
potentiation and synaptic transmission and also induces morphological 
changes on pyramidal neurons. BDNF is synthesized in neurons as a 
preproBDNF and then cleaved to form proBDNF, which can be secreted by 
the cell and is active by itself (Sebastiao et al. 2011). Responses to BDNF 
are mediated by the interaction with its receptor TrkB. Binding of BDNF 
rapidly activates TrkB activity, which in turn triggers multiple intracellular 
signaling pathways. In the other hand, proneurotrophines, the precursors of 
mature neurotrphines, can activate the neurotrophin receptor p75 (p75NTR) 
that promotes apoptotic cell death; this pathway is especially relevant after 
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brain injury or in neurodegenerative processes (Reichardt 2006). Recent 
studies have demonstrated that proBDNF has also an important role in long 
term depression, while mature BDNF has an important role in long term 
potentiation (Sebastiao et al. 2011). There are several factors like exercise, 
brain activity, hormone levels, cholesterol influencing neurotrophin 
expression.  In this regard, a recent report demonstrate BDNF increases the 
synthesis of cholesterol in neurons, and in turns pharmacological depletion 
of cholesterol reduces BDNF-dependent synaptic transmission (Suzuki et 
al. 2007). In general terms, BDNF is able to modulate multiple processes in 
the brain and multiple factors are able to regulate BDNF and TrkB 
expression. Finally, it is important to note the relation found between levels 
of BDNF and TrkB and some pathologies such as Alzheimer disease, 
Parkinson disease and depression (Smith 1996; Mattson 2008; Cirulli et al. 
2009).   
 
2.2 The role of Thyroid Hormones in the CNS  
 
Thyroid hormones are essential for life both in adults and during 
development. In adults, modifications of thyroid levels lead to various 
clinical manifestations. For example, hypothyroidism causes lethargy, 
hyporeflexia and poor motor coordination, and subclinical hypothyroidism 
is often associated with memory impairment and to bipolar affective 
disorders, depression, or loss of cognitive functions, especially in the 
elderly. Hyperthyroidism causes anxiety, irritability, and hypereflexia. 
Both, hypothyroidism or hyperthyroidism can lead to mood disorders, 
dementia, confusion, and personality changes. However, when observed in 
adults these disorders are usually reversible with proper treatment, 
indicating that thyroid hormone alterations of adult onset do not leave 
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permanent structural defects. This is not the same for thyroid alterations 
produced during development, whose hormones are essential for brain 
development and to regulate proliferation migration and differentiation of 
neural cells. In addition, this regulation is time and region dependent, 
leading to a variety of defects according to the moment at which thyroid 
alteration is produced (Santisteban et al. 2005). Thyroid hormone 
deficiencies, even of short duration during development, may lead to 
irreversible brain damage. For instance, neonatal hypothyroidism results in 
altered neuronal structure and function, including the reduction in neurite 
outgrowth, synaptogenesis and dendritic arborisation and altered 
myelination (Thompson et al. 2000). 
 
The high plasticity of the CNS during developmental period is required for 
adaptation, but also generates vulnerability to environmental conditions. As 
seen above, any alteration on multiple factors influencing CNS 
development may affect its normal course and induce permanent changes. 
Some environmental pollutants, such as dioxins, pesticides, polychlorinated 
biphenyls (PCBs) and Polybrominated Diphenyl Ethers (PBDEs), have 
potential impact on the Endocrine System and the Nervous System (Masuo 
et al. 2011).  
 
2. Polybrominated diphenyl ethers (PBDEs) 
 
Polybrominated diphenyl ethers (PBDEs) are a set of chemical substances 
widely used as flame-retardants due to their capacity to delay ignition of 
fires, their thermal stability and their low cost. PBDEs are present in a large 
variety of consumer products such as polyurethane foams used in furniture, 
UNIVERSITAT ROVIRA I VIRGILI 
NEUROBEHAVIOURAL EFFECTS ASSOCIATED WITH POSTNATAL EXPOSURE TO DECABROMODIPHENYL ETHER IN APOE2, 
APOE3 AND APOE4 TRANSGENIC MICE 
Ingrid Reverté Soler 
DL:T. 162-2012 
                   Introduction  
    34 
mattresses, carpet pads and automobile seats and styrene plastics used in 
textiles and for electrical appliances, such as computers and televisions. 
PBDEs are released to the environment by volatilization or waste 
incineration. They also accumulate in wildlife, rise up the food chain and 
arrive this way to the human beings. Although they save lives, 
toxicological studies in the last decade have provided increasing evidence 
that these chemicals accumulate in the environment and in living organisms 
and may cause hepatic, endocrine, and neurodevelopmental toxicity 
(Darnerud et al. 2001; Talsness 2008). 
 
2.1 Chemical structure  
 
 
PBDEs are a group of brominated compounds within which from 1 to 10 
bromine atoms are attached to a diphenyl ether molecule. The general 








2.2 PBDE congeners 
 
There are 209 different congeners of PBDEs. These congeners are 
numbered according to the International Union of Pure and Applied 
Chemistry (IUPAC) with the same system used for the Polychlorinated 
 
Figure 1. Polybrominated diphenyl ether (PBDE) chemical structure 
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Biphenyls (PCBs) (Darnerud et al. 2001; Darnerud 2003; Fernandez 2008). 
For convenience, congeners are divided into ten groups from mono- to 
deca-BDE depending on the number of bromine atoms (Darnerud et al. 
2001; Talsness 2008) (Table 1). PBDEs are usually commercialized as 
mixtures of different congeners named from the predominant form. The 
most common mixtures are pentabrominated, octabrominated and 
decabrominated (BDE-209). Penta- and octa- mixtures production was 
banned in the European Union in 2004, and in several states in the U.S.A. 
As a consequence, the use of the BDE-209 increased and has become the 
most widely used PBDE globally (Costa et al. 2007). In the European 
Union BDE-209 has been banned for use in electrical and electrochemical 
applications since July 1, 2008 ((EFSA) 2011). Despite these regulations, 
BDE-209 is still present in the environment and foodstuffs. For this reason 
it is important to increase our knowledge on possible adverse effects 
produced by BDE-209.   
 
Table 1. Polybromodiphenyl ether (PBDE) congeners 
Form Bromine atoms Congeners 
Bromodiphenyl ethers 1 BDE-001 – BDE- 003 
Dibromodiphenyl ethers 2 BDE-004 – BDE- 015 
Tribromodiphenyl ethers 3 BDE-016 – BDE- 039 
Tetrabromodiphenyl ethers 4 BDE-040 – BDE- 081 
Pentabromodiphenyl ethers 5 BDE-082 – BDE- 127 
Hexabromodiphenyl ethers 6 BDE-128 – BDE- 169 
Heptabromodiphenyl ethers 7 BDE-170 – BDE- 193 
Octabromodiphenyl ethers 8 BDE-194 – BDE- 205 
Nonabromodiphenyl ethers 9 BDE-206 – BDE- 208 
Decabromodiphenyl ethers 10 BDE-209 
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2.3 PBDEs in the environment 
 
PBDEs are released into the environment mainly by the incineration of 
waste and through sewage. Volatilization of PBDEs from consumer 
products into the surrounding air during their lifecycle is also significant 
because they are not fixed in the polymer product through chemical binding 
(Darnerud et al. 2001; Talsness 2008). PBDEs have very low water 
solubility, tend to accumulate in sediments and are not easily degraded, so 
they may last in the environment for years, being considered persistent 
organic pollutants (POPs). Levels of PBDEs have been found in air, sludge, 
water and sediments in many countries, but also in indoor air and house 
dust. Levels of PBDEs have also been detected in wildlife including 
aquatic, terrestrial and avian organisms throughout the planet, supporting 
the idea that PBDE are spread in the environment. In humans, significant 
levels of PBDEs have been detected in adipose tissue, serum and breast 
milk (Darnerud et al. 2001; Costa et al. 2007). Globally, the internal human 
concentrations vary between countries and continents. Levels in North 
American are generally 10 to 100 times higher than those in Europe or Asia 
(Fernandez 2008). 
PBDEs accumulate in the biota because they are highly lipophilic and quite 
resistance to physical, chemical, and biological degradation. Higher 
brominated compounds, such as BDE-209, are more resistant to 
degradation but they can suffer debromination by exposure to ultraviolet 
(UV) light and sunlight. Incineration of PBDEs can develop into the 
formation of polybrominated dibenzo-p-dioxins and dibenzofurans, 
compounds that are even more toxic and persistent than PBDEs. Microbial 
degradation is limited and is also related to the number of bromine atoms of 
the compound (Darnerud et al. 2001; Costa et al. 2007).  
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2.4 Human exposure pathways  
 
Diet is considered the main route of PBDE exposure to, but high levels of 
the contaminant found in human samples cannot be explained solely by 
dietary intake (Costa et al. 2007; Talsness 2008). The indoor environment 
has been suggested as another important means of exposure, as significant 
levels of PBDEs have been detected in house air and dust. Occupational 
exposure is another matter of concern, affecting mostly electrical and 
electronic equipment waste management workers and computer technicians 
(Costa et al. 2007). Dermal uptake is considered a non-significant route of 
exposure (Fernandez 2008). In babies, oral intake through breast milk is the 




Diet is considered the main route of PBDE exposure. PBDEs present in the 
environment biomagnify in the food chain and accumulate in fatty foods 
due to their lipophilic properties (Darnerud et al. 2001; Costa et al. 2007). 
Contamination is highest in fish, then in meat and lowest in dairy products 
(Fernandez 2008). In a study carried out in our laboratory, levels of  
PBDEs were determined in samples of foodstuffs consumed by the 
population of Catalonia, Northeast Spain. The highest concentration of total 
PBDEs was found in fish and shellfish, followed by oils and fats and 
bakery products. For most food groups, BDE-47 and BDE-99 congeners 
showed the highest levels. The dietary intake of PBDEs was estimated in 
1.1 ng/kg body weight/day (Domingo et al. 2008).  
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For infants, the main route of exposure to PBDEs is through breast milk 
intake, which is the largest contributor to lifetime exposure (Talsness 
2008). A study determined PBDE concentration in mothers living in the 
county of Tarragona (Spain) who were breast-feeding. The PBDE 
concentrations (sum 15 congeners) ranged from 0.57 ng/g fat to 5.9 ng/g 
fat, with a mean value of 2.5 ng/g fat (Schuhmacher et al. 2009). Another 
study in California (USA) determined that BDE-209 accumulates in breast 
milk and is able to transfer from the mother to the infant (Park et al. 2011). 
There is evidence that humans are exposed to PBDEs even before birth, as 





Non-dietary ingestion of dust and soil is also an important contributor of 
exposure throughout life to brominated flame retardants (BFRs), since diet 
cannot by itself explain such high levels found in human samples.  
The contamination of dust and indoor air occurs because of lower 
brominated compounds being very volatile and the formation of dust when 
electronic devices are switched on. This exposure pathway is especially 
important for young children because they often play on the floor and put 
objects into their mouth. For toddlers, dust ingestion is estimated to account 
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 Toxicokinetics  
 
The understanding on the kinetics of PBDEs once they entered in the body 
is essential to determine their potential toxicity and its mechanisms of 
action. The absorption, distribution, metabolism and excretion of PBDEs 
are depending on the bromine content of the compound. It has to be noted 
that those parameters also varies among species, generally metabolism is 




Lipophilic compounds with low molecular weight are easily absorbed by 
passive transport, while those with high molecular weight require 
transporter proteins. For this reason, the assimilation of lower brominated 
congeners is favoured, while BDE-209 have been shown poor absorption, 




Tissue distribution of PBDEs in rodents depends on the congener and the 
means and period of exposure. In general, the target tissues are fat, muscle, 
skin, liver, adrenals, kidney and heart. Although concentrations in brain are 
low, hexaBDE compounds showed a 10 times higher brain concentration 
than the tetraBDE compounds (Morck et al. 2003; Staskal et al. 2006).  
 
Despite very low water solubility BDE-209 has a limited uptake by 
adipocytes, unlike lower brominated compounds ((EPA) 2008). 
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Approximately 9% of BDE-209 has been shown to remain in the body a 
week after exposure, and the highest concentrations were found in adrenals, 
kidneys, heart, and liver (Morck et al. 2003). In developing mice BDE-209 
distributed all over the body and increased in the brain during the first week 
after an oral administration. BDE-209 concentrations in the brain were 
higher in mice exposed in PND3 and PND10 compared to those exposed 
on PND19, highlighting the importance of the time at exposure, above all 
during critical periods in development (Viberg et al. 2003). In addition, 
human and animal data demonstrated that BDE-209 is able to cross the 




Metabolism of PBDEs occurs in two phases in the intestine. In Phase I, a 
reactive polar group is introduced, giving rise to a hydroxylated metabolite 
(OH-PBDE) facilitating the clearance of the compound from the organism. 
In Phase II, a conjugation reaction in the polar group converts the OH- into 
a methoxylated metabolite (MeOPBDE). This makes the compound more 
hydrophilic and increases its excretion. However, PBDE metabolites are 
quite hydrophobic and remain in the organism, being even more toxic than 
the original compound (Darnerud et al. 2001; Fernandez 2008). 
 
The highest brominated compound, BDE-209, suffers debromination in the 
first step of metabolize. After that, the debrominated metabolites undergo 
hydroxylation to form phenols or catechols. Cathecols are then methylated 
to form hydroxymethoxylated metabolites, and the reactive intermediates 
and phenolic compounds are rapidly conjugated via Phase II, giving rise to 
water-soluble metabolites which would be easily excreted ((EFSA) 2011).  
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Excretion 
 
Elimination of PBDEs is low, and mainly occurs through fecal excretion. 
Elimination of BDE-209 is faster compared to low brominated compounds 
(Darnerud et al. 2001; Morck et al. 2003; Staskal et al. 2006). It is 
important to note that toxicokinetics of PBDEs are different in developing 
pups than in adult mice, since the excretion capacity is lower in the pups 
and this lead to increase the concentrations of PBDEs in target tissues 
during critical stages of development (Staskal et al. 2006). In humans, there 
is also evidence of differences between infants and adults in drug 
metabolism, distribution and excretion (Strolin Benedetti et al. 2005).  
 
2.5 Toxicity of PBDEs  
 
PBDEs are of primary interest to European and American Health 
Authorities, because of their extensive presence in the environment, their 
similar structure to substances considered hazardous, such as PCBs, and for 
the increasing evidence of their toxicity. A great amount of data is available 
on the toxicity of PBDEs, although little information is known about the 
human adverse health effects.  
 
Acute toxicity of PBDEs differs between the different congeners and is 
generally low, with an oral LD50 higher than 5g/kg bw, and they do not 
induce genotoxicity (Darnerud et al. 2001). After acute exposure rodents 
show evident signs of toxicity, such as skin and eye irritation, reduced 
growth and tremors. Different congeners and mixtures show different toxic 
effects at different dosages. BDE-209 shows the lowest acute toxicity, 
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probably because of their poor absorption, while pentaDBE show clear 
toxicity and mortality after exposure to high doses (Darnerud et al. 2001).  
 
After chronic exposure to PBDEs, the target organs are the liver, the kidney 
and the thyroid gland. These organs are generally enlarged and 
degenerated, and penta- and octa- BDEs induced an increase of porphyrins 
in the liver (Darnerud et al. 2001).  
 
Exposure toPBDE during gestation and the neonatal period has been shown 
to produce physical and neurobehavioural effects and alterations in the 
endocrine and reproductive systems in the offspring. Some of these effects 
are similar to those induced by PCBs. Despite their structural similarity 
with PCB, the toxic effects exerted by PBDEs occur by different 
mechanisms which are still not fully known (Darnerud et al. 2001; Costa et 
al. 2007).  
 
Effects on reproductive system 
 
The exposure to penta- and tetraBDEs during gestation causes alterations in 
the male and female reproductive system.  
A reduction in the number of sperm and spermatid in males, and changes in 
the ovarian maturation and structure in females, were observed in adult 
rodent offspring administered PBDEs during gestation (Costa et al. 2007; 
Talsness et al. 2008). Antiandrogenic effects of PBDEs were observed in 
vitro and in vivo; delayed puberty and reduced growth of the androgen-
dependent tissues have been observed in males (Stoker et al. 2004; Stoker 
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et al. 2005). Mithocondrial damage in germinal cells has been observed in 
both males and females (Talsness 2008).  
The exposure to the highest brominated compound, BDE-209, has been 
shown to increase the production of sperm reactive oxygen species (ROS) 
and to slightly impair sperm motility, but it has not been shown to affect 
the sperm count, morphology or DNA content (Tseng et al. 2006; Talsness 
2008).  
PBDEs are able to affect circulating sex steroid levels and to interact with 
androgen, progesterone and estrogen receptors (Lilienthal et al. 2006; Costa 
et al. 2007). Androgens and estrogens not only lead to sex differentiation 
but can also affect brain and behaviour, can promote neuronal viability and 
can give neuroprotection (Jordan et al. 2008).  
 
Endocrine disruption effects 
 
PBDEs are considered endocrine disruptors since they are able to disturb 
several points of the system. They have been shown to alter steroid and 
thyroid hormones, which are crucial for regulation of tissue function, 
growth and development, behaviour and mood.  
 
The effects of PBDEs on the sexual hormones have been described in the 
previous section as they mediate the reproductive system impairments.  A 
change in the sexually dimorphic behaviour sweet preference was also 
observed in rodent males, who exhibited a feminization of this behaviour. 
Sweet preference behaviour is modulated by the aromatase activity at the 
pre-optic area of the hypothalamus, whose formation and organization is 
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affected by testosterone levels during gestation (Lilienthal et al. 2006; 
Talsness 2008).  
 
PBDEs have also been found to alter the release of vasopressin in the 
supraoptic nuclei of the hypothalamus. This hormone play a role in  NS 
development and it is implicated in fluid homeostasis, cardiovascular 
control and learning and memory processes (Coburn et al. 2007). 
 
The thyroid hormone is the principal target of PBDE action in the 
endocrine system. Decreased concentrations of the total and free thyroxin 
(T4) hormone have been widely reported after the administration of tetra- 
and pentaBDE mixtures (Zhou et al. 2002; Branchi et al. 2003; Stoker et al. 
2004; Ellis-Hutchings et al. 2006; Darnerud et al. 2007; Kuriyama et al. 
2007; Richardson et al. 2008; Driscoll et al. 2009). Several mechanisms 
have been proposed for the PBDE disruption of thyroid equilibrium. 
Hydroxylated BDEs show a similar structure to thyroid hormones, so they 
can compete with the hormone to bind the thyroxin plasma transporter 
transthyretin or bind directly to thyroid hormone receptors. An increased 
metabolism of T4, by the induction of UDGPT, has been also suggested to 
cause the reduction in the hormone levels (Meerts et al. 2000; Richardson 
et al. 2008; Talsness 2008). Moreover, Talsness and colleagues found 
persistent histological and morphometric changes in the thyroid gland at 3 
months of age after a single low dose administration of BDE-47 at GD6 
(Talsness et al. 2008).  
 
Studies on the effects of BDE-209 on thyroid hormone levels are less 
consistent; some of them found no effect on T4 levels, one study found a 
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decrease in T4 at high doses, and some studies observed differential gender 
effects in T3 and T4 levels ((EFSA) 2011).  
 
In humans, data on the effects of PBDE on hormones is scarce and 
divergent. An American study tested 405 adult males and found increased 
thyroglobulin antibodies and increased T4 levels associated with PBDEs in 
blood serum (Turyk et al. 2008). Another study detected decreased TSH 
levels, but intact T4 related to higher PBDE levels in blood of 270 
Californian pregnant women (Chevrier et al. 2010). Nevertheless, a recent 
study used linear regression to examine TSH levels in 239 neonates and 
levels of BFRs in their mothers’ breast milk in a Norwegian population and 
they did not find any association between thyroid-stimulating hormone and 
to PBDE exposure (Eggesbo et al. 2011). More studies are required to 
determine possible endocrine disruptive effects of PBDEs in the human 
population at different levels of exposure.  
 
Thyroid hormones have an essential role during brain development and for 
the normal function of the CNS, as they are implicated in the regulation of 
neuronal growth and synaptogenesis, and their receptors are distributed 
throughout the CNS. Dysfunctions of this system during critical 
developmental periods, cause structural and biochemical changes in the 
CNS which leads to anomalous or delayed development and can explain 
the disrupted neurobehaviour observed in animals and humans during 
thyroid dysfunctions (Ahmed et al. 2008).  
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Neurodevelopmental effects 
 
PBDE exposure to during development is the major concern. There are 
some factors that make this population more vulnerable to toxic insults.  
Children are exposed to higher levels of contaminants since they drink 
more, eat more and breathe more in relation to their body weight compared 
to adults. In addition, many organ systems in children are still immature. 
Infants have reduced capacity to metabolize, detoxify, and excrete many 
toxicants. Of special interest are the possible effects of toxicants on the 
CNS, because the brain is the most immature organ at birth and especially 
vulnerable to damage.   
 
Some effects were observed on growth and development in mice after 
PBDE exposure. Gee et al. (2008) found differences in neuromotor 
development on specific days and in specific tests, after a single oral dose 
of 10 or 30 mg/kg of BDE-47 on PND10. Branchi et al. (2002) found a 
delay in the ability to climb in mice that had been exposed to 30mg/kg of 
BDE-99 from GD6 to PND21. Mice exposed to 20mg/kg of BDE-209 from 
PND2 to PND15 showed a delay in the acquisition of palpebral reflex 
(Branchi et al. 2002; Rice et al. 2007; Gee et al. 2008).  
 
The neurobehavioural effects of perinatal exposure to PBDE have been 
studied widely in adult offspring. Alteration in locomotor activity has been 
found after administration of tetra-, penta- and decaBDE compounds 
during the perinatal period in both rats and mice. Impaired habituation to 
new spaces, characterized by prior low activity followed by hyperactivity, 
have been reported in neonatal exposed rodents at 1,2,4,6 and 8 months of 
age (Eriksson et al. 2002; Viberg et al. 2002; Viberg et al. 2003; Viberg et 
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al. 2003; Viberg et al. 2004; Branchi et al. 2005; Kuriyama et al. 2007; 
Rice et al. 2007; Viberg et al. 2007; Gee et al. 2008; Johansson et al. 2008; 
Viberg 2009). Some effects in learning and attention have also been 
reported after neonatal PBDE exposure. In a 5-choice serial reaction time 
task (5CSRTT), rats administered pentaBDE chronically since PND1 
showed deficits in sustained attention and inhibitory control, while those 
exposed from PND6 to PND12 showed impairment in learning the task but 
no effect on sustained attention or inhibitory control (Dufault et al. 2005; 
Driscoll et al. 2009). Mice exposed to hexaBDE on PND10 showed deficits 
in spatial learning in the MWM task at six months of age (Viberg et al. 
2003), but a single oral dose of BDE-99 in adult rats did not show any 
effect on the passive avoidance and the MWM tasks (Belles et al. 2010). 
Mice exposed to decaBDE from PND2 to PND15 showed less efficient 
performances than controls in an operant fixed interval task, and slower 
learning and more perseverance errors in a light-dark discrimination task at 
16 months of age. The same mice showed only a minimal effect on the 
light-dark discrimination at young age, indicating that the effects of PBDE 
exposure appeared much later (Rice et al. 2009).  
 
Some studies on human children also indicate a relationship between 
PBDE levels and neurobehavioural and cognitive impairment. Herbstman 
et al. (2010) estimated the median concentrations of three PBDE congeners 
(BDE-47, 99, and 100) in cord blood and found an association between 
high levels of PBDEs and lower mental and psychomotor skills at 12, 48 
and 72 months of age. In the same direction, Gascon et al. (2011) 
determined the levels of PBDE-47 in cord blood and at 4 years old, and 
found a positive association between BDE-47 exposure and a significant 
increase in the risk of attention deficit symptoms and poor social 
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competence and non-significant lower cognitive and motor scores 
(Herbstman et al. 2010; Gascon et al. 2011).  
 
Most alterations in spontaneous behaviour have been noted after PBDE 
exposure during the brain growth spurt (BGS). The BGS is a fundamental 
period during which neurite growth occurs, along with the establishment of 
neural connections, axonal myelinization, changes in the cholinergic 
system and the acquisition of motor and sensory skills. In humans, the BGS 
extends from the third term of pregnancy to the first two years of age.  In 
rodents, this period covers the first 3-4 weeks after birth and reaches its 
peak around the postnatal PND10 (Eriksson et al. 2002; Viberg et al. 2007). 
In fact, PND10 has been identified as a critical point of time in which 
PBDE exposure produces neurobehavioural alterations in rats and mice. 
However, some studies indicate that this critical point might be different 
for the BDE-209 compound, which would induce its maximum effects 
when administered on PND3, probably because it exerts its mechanisms by 
the creation of debrominated forms that take some days to occur (Talsness 
2008). 
 
2.6 Mechanisms of action  
 
Among the potential mechanisms for developmental toxicity induced by 
PBDEs are the direct genotoxicity, gene regulation, epigenetics, cell 
signalling, abnormal neuronal development, changes in neurotransmitter 
release and metabolism, neuroinflammation, oxidative damage and 
neuroendocrine dysregulation (Miodovnik 2011).   
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Several in vitro and in vivo studies investigated the role of PBDEs on the 
activation of receptors leading the cytochrome P450 enzyme gene 
expression. Initial research suggested that PBDEs may activate the Aryl-
hydrocarbon receptor (AhR), a receptor that induces xenobiotic 
metabolizing enzymes, but which have been shown to elicit the production 
of toxic metabolites in polycyclic aromatic hydrocarbons (PAHs), 
polychlorinated dibenzo-p-dioxins and PCBs. More recent studies suggest 
that PBDEs can bind the AhR but do not activate its signaling pathway or 
induce AhR-gene expression. Like PCBs, PBDEs activate the pregnane X 
receptor (PXR) and constitutive androstane receptor (CAR), which lead to 
an increase in CYP3A and CYP2B expression in rat liver (Talsness 2008). 
The activation of PXR and CAR receptors may trigger the reproductive and 
hormone disruptor effects observed in PBDEs ((EFSA) 2011).  
 
Oxidative damage was reported after exposure to pentaBDE congener. 
BDE-99 was shown to decrease antioxidant enzyme levels and increase 
free radicals in the hippocampus and cerebellum after perinatal (Cheng et 
al. 2009) and adult exposure (Belles et al. 2010).  
 
PBDEs have been shown to disturb intracellular signaling events, including 
calcium homeostasis and subsequent events such as protein kinase C (PKC) 
in the frontal cortex, cerebellum, and hippocampus, in a similar manner to 
PCB. These signalling pathways have been implicated in learning and 
memory and are critical for the normal function and development of the 
nervous system (Kodavanti et al. 2002; Kodavanti et al. 2005).  
 
Alterations in proteins involved in cytoskeleton and in neuronal survival, 
growth and synaptogenesis such as BDNF, Gap-43 and CaMKII have also 
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been demonstrated after PBDE exposure. These proteins are required for 
cell migration, proliferation and differentiation during the BGS (Talsness 
2008). Dingemans et al. (2007) observed that BDE-47 exposure reduced 
LTP in the CA1 area of the hippocampus and reduced postsynaptic proteins 
implicated in synaptic plasticity, such as some glutamate receptor subunits 
and CaMKII (Dingemans et al. 2007).  
 
Altered cholinergic system was proposed as an inductor of  motor and 
learning deficits that result from PBDE exposure, since altered responses to 
nicotine (nicotinic agonist) and to scopolamine (muscarinic antagonist), 
and decreased cholinergic receptors have been reported (Viberg et al. 2002; 
Viberg et al. 2003; Dufault et al. 2005; Viberg et al. 2007; Johansson et al. 
2008; Talsness 2008). This disturbance in the cholinergic system might 
occur after PBDE thyroid hormone disruption, since hypotiroidism has 
been shown to reduce the expression of the enzyme responsible for 
acetylcholine production (Chat) (Talsness 2008).  
 
Extensive research has shown that PBDEs affect neurodevelopment at 
molecular, cellular and functional level and those alterations remain for a 
long time or even worsen with age.  
 
3. Apolipoprotein E (ApoE) 
 
Human Apolipoprotein E (ApoE) belongs to the family of soluble 
apolipoproteins and is implicated in cholesterol and phospholipid transport, 
and it is involved in neuroprotection in the brain. ApoE has three different 
alleles in the population, one of them, ApoE4, has been identified as a 
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major genetic risk for developing Alzheimer’s disease in the elderly and as 
more susceptible to cognitive impairments.  
  
3.1 Apolipoprotein E structure and polimorphisms 
 
 
ApoE is a protein consisting of 299 amino acids, codified in a gene 
(APOE) located in the 19-chromosome in humans. ApoE contains two 
independent folded helical lipid-domains, which are able to switch from a 
lipid free state to a lipid bound state. The C-domain has α-helical structure 
and is the principal lipid-binding region of the protein. The N-domain is a 
four-helix bundle and is the receptor-binding region. ApoE is polymorphic 
with three different structural conformations of the protein that provide 














Figure 2. Apolipoprotein E (ApoE) structure  
 
* Source of the image (Hatters et al. 2006) 
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The three allelic isoforms carry different amino acids at positions 112 and 
158; ApoE3, the most common isoform, contains a cysteine and an 
arginine, while ApoE2, the least common, contains two cysteines, and 
ApoE4 contains two arginines at these positions. ApoE3 and ApoE4 have a 
similar low-density lipoprotein (LDL) receptor affinity, while the structural 
conformation of ApoE2 results in a weak LDL receptor affinity. Therefore 
ApoE2 is associated to type III hyperlipoproteinemia, a lipid disorder 
characterized by increased plasma levels of cholesterol and triglycerides 
and premature cardiovascular disease. The major association of ApoE with 
disease is attributed to the ApoE4 isoform, which is associated with the 
greatest risk of developing Alzheimer’s disease and other neurological 
conditions along with higher cardiovascular risk. Two structural properties 
of ApoE4 might be responsible for its dysfunction. The first is that ApoE4 
has less conformational stability than ApoE2 and ApoE3. The second is a 
domain interaction between the C and N-domain generated by the arginine 
location at 112 position, which leads to ApoE4 binding preferentially to 
LDL and very low density lipoproteins (VLDL), while ApoE2 and ApoE3 
bind preferentially to high density lipoproteins (HDL) (Hatters et al. 2006). 
 
3.2 Apolipoprotein E function 
 
ApoE is mainly synthesized in the liver and it takes up lipoproteins 
containing cholesterol and phospholipids and distributes them to where 
they are used or stored. ApoE transports lipids both in plasma and in the 
CNS (Arendt 2001; Hatters et al. 2006). In the brain, ApoE is generated in 
astrocytes and is involved in neuroprotection; it has a role in neuronal 
growth and maintaining the synaptic integrity after injuries or ageing 
(Arendt 2001; Lanterna et al. 2009). The ApoE2 allele provides the most 
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neuroprotection, ApoE3 has an intermediate neuroprotective effect and 
ApoE4 is the least neuroprotective allele.  
 
The brain is the most cholesterol-rich organ in the body. Cholesterol is an 
important precursor of hormones and signalling molecules and plays an 
important role in cells plasma membrane (Jenner et al. 2010; Gibson 2011). 
Important amounts of cholesterol are required during brain development 
and in all processes requiring the addition of new membranes such as the 
growth of neurites or the reparation or regeneration processes (Gibson 
2011). Cholesterol cannot cross the blood brain barrier and it is synthesized 
in neurons and glial cells, that is, cholesterol synthesis and metabolism in 
brain is dependent of its own regulatory mechanisms and independent of 
the periphery. Once cholesterol is synthesized, several mechanisms 
including ApoE transport and interaction with LDL receptors contribute to 
its distribution and localization properly in the membranes (Jenner et al. 
2010).  Cholesterol plays a crucial role in the organization of lipid rafts 
microdomains in the membranes which are specialized in signal 
transduction, and recent reviews have highlighted a role for lipid rafts in 
neurotrophin signaling. Moreover, lipid raft signaling and clustering may 
be important for the assembly of components that form neuronal synapses 
in the central nervous system (Paratcha et al. 2002). The association of 
cholesterol and neurotrophines has been reported, but seems to be complex. 
A recent report demonstrate BDNF increase the synthesis of cholesterol in 
neurons (Suzuki et al. 2007) and cholesterol deprivation in vitro increases 
the activity of TrkB (Martin et al. 2008). While other authors refer 
increased BDNF levels after high cholesterol diet in wild and ApoE Knock 
out mice and increase levels of TrkB in ApoE Knock out mice (Wang et al. 
2011). 
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3.3 Apolipoprotein E and Alzheimer’s disease 
 
Alzheimer’s disease (AD) is a neurodegerative pathology characterized by 
a progressive deterioration of cognitive capacity. A familiar form of the 
disease is characterized by early onset and mutations in the amyloid 
precursor protein (APP), presenilin 1 (PSEN1) and presenilin 2 (PSEN2) 
genes. The late-onset form of Alzheimer’s disease is the most common 
neurodegenerative disease in the elderly in which genetic and 
environmental factors are involved in its aetiology. Genes that increase the 
risk of developing late-onset AD are APOE and sortilin-related receptor 
(SORL1). At the anatomical-pathological level, AD exhibits an abnormal 
accumulation of tau protein at intracellular level, called neurofibrillary 
tangles, and aggregates of insoluble β-amyloid protein at the extracellular 
level, named beta amyloid plaques (Findeis 2007; Reitz et al. 2009; 
Querfurth et al. 2010). The ApoE4 allele has been identified as a major 
genetic risk factor for developing Alzheimer’s disease, accounting for more 
than 50% of the risk (Higgins et al. 1997; Raber et al. 2004; Grootendorst 
et al. 2005). Multiple mechanisms have been proposed to explain the 
relationship between ApoE and AD. There is evidence that ApoE4 
increases the rate and extent of amyloid plaques and can contribute to the 
development of tau pathologies (Raber et al. 2004; Findeis 2007). ApoE4 
seems to have little ability for Aβ clearance since it reduces the expression 
of Aβ degrading enzyme IDE by binding its receptor and activating NMDA 
receptor pathway (Du et al. 2009). It has also been suggested that ApoE4 
might have insufficient levels of functional ApoE required to maintain 
neuronal health, since lower levels of ApoE were detected in plasma, brain 
and cerebrospinal fluid in mice (Sullivan et al. 2009). Colton et al. (2005) 
found that the ApoE4 gene promotes a pro-inflammatory macrophage 
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phenotype in neonatal microglia, and furthermore, ApoE4 has been 
associated with mitochondrial disfunctions, alterations in myelination and 
increased levels of  isoprostanes as oxidative stress markers (Colton et al. 
2005; Huang 2006). The deficiency of ApoE4 in synaptic function, 
energetic metabolism, neuronal repair and protection against reactive 
oxygen species might explain its association with neurodegenerative 
processes. Moreover, some data indicate that altered functioning might be 
related with the lower capacity of androgens to bind the androgenic 
receptor in ApoE4 carriers (Raber 2008), which suggests that ApoE4 
carriers can be especially vulnerable when they are exposed to endocrine 
disruptors.  
 
3.4 Apolipoprotein E, cognitive performance and 
neurobehaviour 
 
The effects of the ApoE4 allele are beyond the increased risk of developing 
a neurodegenerative disease, inasmuch as ApoE4 also modulates the 
cognitive function. The presence of at least one ε4 allele was associated 
with faster cognitive decline in AD patients (Reitz et al. 2009). In a sample 
of mild AD patients, ApoE4 carriers had significantly greater impairment 
on measures of memory retention and showed greater medial temporal lobe 
atrophy, whereas non-carriers were more impaired on tests of working 
memory, executive control and lexical access, and had greater 
frontoparietal atrophy (Wolk et al. 2010).  ApoE also exerts its effect in 
cognitively normal subjects or preclinical stages of the disease (Reitz et al. 
2009). Compared to ApoE3, ApoE4 also increases the risk of developing 
cognitive impairments after several environmental conditions such as 
neurotrauma, ischemia, cardiopulmonary bypass surgery, human 
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immunodeficiency virus infection, and it is also associated with cognitive 
impairments that occur with normal aging (van Meer et al. 2007). There is 
evidence that old, non-demented ApoE4 carriers perform worse than non-
carriers in object recognition tasks, episodic memory tasks and spatial 
navigation tests (Berteau-Pavy et al. 2007; De Blasi et al. 2009; Kukolja et 
al. 2010) and have an impaired attention and working memory (Greenwood 
et al. 2005).  Memory decline associated with the ApoE4 genotype has also 
been reported in middle-aged populations (Bour et al. 2008). Nowadays, 
there is an increasing interest in know what the role of ApoE4 in cognitive 
function is in young people. Human studies have reported changes in 
activity in prefrontal and middle-temporal areas, and in the hippocampus in 
young healthy ApoE4 carriers while memory tasks are being performed, 
although they had equal or even better results in cognitive and memory 
tasks than non-carriers (Mondadori et al. 2007; Dennis et al. 2009). It was 
been reported that young human ApoE4 carriers with normal cognitive 
ratings showed functional abnormalities assessed by MRI in the posterior 
cingular, parietal, temporal, and prefrontal cortices similar to those found in 
middle-aged ApoE4 carriers and patients with probable Alzheimer’s 
disease, although they did not find any differences in cognitive and 
memory measures (Reiman et al. 2004). Similarly, young Apoe4 carriers 
showed equivalent scores to non-carriers in memory tasks, information-
processing speed, attention, and executive skills (Dennis et al. 2009). 
Contrary to these findings, ApoE4 children aged 7-10 did not show any 
target preference in the spatial test Memory island, which indicates no 
retention of the task in this group (Acevedo et al. 2010). Moreover, ApoE4 
carriers aged 16-30 years old performed worse than ApoE3 carriers in a 
maze test consisting of learning a route (Alexander et al. 2007). The data 
suggests that contrary to general cognitive ability, spatial learning and 
UNIVERSITAT ROVIRA I VIRGILI 
NEUROBEHAVIOURAL EFFECTS ASSOCIATED WITH POSTNATAL EXPOSURE TO DECABROMODIPHENYL ETHER IN APOE2, 
APOE3 AND APOE4 TRANSGENIC MICE 
Ingrid Reverté Soler 
DL:T. 162-2012 
                   Introduction  
    57
memory might be particularly sensitive for detecting the negative effects of 
apoE4 at younger ages (Siegel et al. 2010). 
 
 Studies with rodents have reported ApoE isoform-dependent effects on 
cognitive function.  Studies with mice expressing ApoE under the control 
of the neuron–specific enolase (NSE) and under control of the glial 
fibrillary acidic protein (GFAP) found sex and age dependent effects. 
Raber and co-workers found subtle differences in Morris Water Maze 
acquisition in female NSE-ApoE4 at 3 months of age, and these subtle 
differences became evidently impaired at 6 months of age in NSE-ApoE4 
females. 18-month-old NSE-ApoE4 females showed impairments both in 
acquisition and retention in the water maze. These indicate that ApoE4-
related cognitive impairments in the Morris Water Maze progressively 
worsen with age (Raber et al. 2000). Similar results as found in 6-months 
NSE-ApoE4 females were found in 6-month-old GFAP-apoE4 female 
mice, proving that the detrimental effects of apoE4 on spatial memory 
retention in the water maze is independent of the cellular source of ApoE 
(van Meer et al. 2007). However, they did not find any differences among 
genotypes in 6-month-old NSE-ApoE males (Raber et al. 1998). Impaired 
performance in the radial arm maze, but not in the Morris Water Maze was 
found in 11-14 month-old GFAP-ApoE4 male mice (Hartman et al. 2001). 
On the contrary, (Pfankuch et al. 2005) found subtle impairments in the 
Morris Water Maze retention test in sham-castrated 6-month-old NSE-
ApoE4 males. 
 
A human ApoE targeted-replacement mouse model, which allows the 
physiological expression of human ApoE isoforms, has also been used to 
assess spatial learning and memory in the Morris Water Maze. Mathis and 
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co-workers found impaired Morris Water Maze retention in both ApoE4 
males and females at 4-5 months of age, and lower improving acquisition 
and impaired retention in ApoE4 females of 15 months of age 
(Grootendorst et al. 2005; Bour et al. 2008). Nevertheless, a recent study 
did not report any deficits, but better performances in acquisition and 
retention of the Morris Water Maze task in ApoE4 mice (Siegel et al. 
2010).  These substantial differences among rodent studies could be due to 
methodological differences in tasks used for the cognitive assessment.  
 
ApoE polimorphisms have also been proposed to modulate anxiety state. 
Increased measures of anxiety are frequently associated with AD (Siegel et 
al. 2010) and ApoE4 carriers have been shown higher levels of plasma 
corticosterone and higher anxiety scores. Anxiety and other non-cognitive 
behavioural changes are a major cause of institutionalisation of AD 
patients, a major concern for their caregivers and negative predictor for 
survival (Robertson et al. 2005; Raber 2007). Increased anxiety levels also 
might contribute to lower performances on cognitive tests (Siegel et al. 
2010).  
 
3.5 Transgenic ApoE models in rodents 
 
The role of ApoE has been studied in different mouse models. First of all, 
the knockout ApoE (0/0) mice were used to evaluate the functions of this 
protein. These initial studies suggested an implication of ApoE in learning 
and memory processes. To evaluate the vulnerability phenotype of ApoE4, 
new mouse models were generated which expressed ApoE under the 
control of neuron-specific-enolase (NSE) or the glial-fibrillary-acidic-
protein (GFAP) promoter. These mouse models provided information about 
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the detrimental effects of ApoE4 on learning and anxiety, but they showed 
differences in expression and distribution of the protein (Grootendorst et al. 
2005; Bour et al. 2008). Finally, the ApoE Human Targeted Replacement 
Mouse model was created to emulate the human condition, since it allows 
expression of the human ApoE protein in the same pattern and level as non-
demented humans and keep the regulatory sequences required for modulate 
ApoE expression intact. This provides a perfect model for studying the 
neurobiology of the human ApoE isoforms (Sullivan et al. 2004).  
 
4. Neurobehavioural assessment 
 
Neurobehavioural research has been a very important tool in neuroscience 
and in the assessment of toxicological effects and genetic factors (Weiss 
1994). Rodents are widely used for neurobehavioural assessment in 
neuropsychiatric and psychopharmacological research since they have 
similar gene functions and share a number of neuroanatomical, 
neurochemical and behavioural commonalities with humans. For these 
reasons multiple tests have been developed to evaluate functional, 
emotional and cognitive abilities in rodent models (Sartori et al. 2011).  
 
4.1 Anxiety and locomotor activity 
 
Anxiety and fear are considered basic emotions, important for drive 
behaviour in humans and animals. Despite fear and anxiety being closely 
related, they are considered different emotions that implicate different 
mechanisms and responses. In neuroscience anxiety is defined as the 
response to an undetermined potentially hazardous situation, while fear is 
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defined as the response to an explicit hazard. Fear and anxiety are adaptive 
responses essential for survival. However, anxiety becomes pathological 
when the response is disproportionate in respect to the stressful agent or is 
inappropriate in a particular context.  Both intrinsic and extrinsic factors 
can affect the anxiety response (Sartori et al. 2011).  
 
Neurobiology of anxiety 
 
The anatomical brain system implicated in the neurobiology of anxiety is 
the limbic system. The amygdala receives projections from olfactive and 
visceral afferent pathways and from the thalamus, which provide sensory 
information about the stressful stimulus. The role of the amygdala is to 
create conditioning to the sensory stimuli and to generate an emotional 
response. For this, the amygdala sends projections to the prefrontal cortex 
(PCF), the hipoccampus, the striatum, the cranial nerve nuclei and the 
hypothalamus.  The PFC enables emotional regulation by the integration of 
information on the emotional history of a stimulus (amygdala), the context 
and time (hippocampus), the internal state (brainstem monoamines), and 
cognitive-mnemonic information (orbital and lateral PFC), and is then able 
to interpret, modify and predict the behavioural response. The hippocampus 
has a role in the generation of contextual fear conditioning. The striatum 
induces changes in the locomotor activity that allows the cessation of the 
exploration and the escape behaviours. The cranial nerves nuclei and the 
hypothalamus are responsible for fear facial expressions and the activation 
of the sympathetic and parasympathetic responses, including the activation 
of the Hypothalamus-Pituitary-Adrenal axis (HPA) axis. Many 
neurotransmitter systems are implicated in the modulation of anxiety; 
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corticosteroids, neuropeptide Y and the noradrenergic system are 
implicated in the stress response mediated by HPA system.  Serotonin, 
dopamine, GABA and glutamate are other neurotransmitter systems 
implicated in the emotional response of anxiety (Kenneth L. Davis et al. 
2002; Sotres-Bayon et al. 2006).  
 
Assessment of anxiety in rodents 
 
Tests of anxiety-related behaviour developed for rodents can be classified 
as conditioned or unconditioned. Conditioned paradigms require training to 
learn the association of the aversive stimulus with a neutral or rewarding 
stimulus. Examples of conditioned paradigms are Vogel-conflict, Fear-
potentiated Startle and Fear Conditioning. Unconditioned paradigms are 
based on ethological behaviour, and use the natural spontaneous reactions 
of the animal to an innate aversive stimulus. Examples of unconditioned 
paradigms include the light/dark test, social interaction, ultrasonic 
vocalization, the holeboard test, the Open Field test and the Elevated Plus 










Figure 3. Unconditioned anxiety paradigms.  
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In these paradigms, rodent behaviours such as avoidance, escape or 
freezing behaviour are used as markers of a state of enhanced anxiety, but 
often referred to as ‘anxiety-related’ or ‘anxiety-like’ behaviour rather than 
as anxiety per se. The Open Field test and the Elevated Plus or Zero Maze 
tests are based on the conflict between exploring a new space and the fear 
that open, high or brightly lit spaces generate in the animal. In these tests, 
the animal is allowed to freely explore the space for a determined time, and 
then the time spent and the activity carried out in the anxious-like spaces 
(centre or opened arms) are taken as measures of anxiety.  Nevertheless the 
mentioned anxiety tests are based on exploration and locomotor activity, so 
the activity levels can act as confounders that prevent taking a pure anxiety 
measure. Discriminate the emotional and non-emotional component of 
animal behaviour is essential in these tests (Vorhees et al. 2006; Ramos 
2008).  
 
4.2 Learning and memory  
 
Neural processes for learning and memory are essential for the individual’s 
adaptation to the environment and may be modulated by different 
endogenous systems. Learning is defined as the acquisition of a stable 
change on behaviour that requires interaction with the environment and 
practice. Memory is the process by which this information is encoded, 
stored and retrieved (Sharma et al. 2010).  
 
Different types of memory can be distinguished based on time or content. 
Depending on the time this memory is stored you can divide memory in 
sensory, working, short-term and long-term. Based on content memory can 
be classified as non-declarative (implicit) and declarative (explicit). Non-
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declarative memory includes skills and habits, conditional learning, non-
associative learning (habituation, sensitisation) and priming. Declarative 
memory comprises semantic (facts) and episodic memory (temporal and 
spatial context). Working and episodic memory are more likely to be 
impaired with age or neurodegenerative processes. (Graef et al. 2011). 
Several mazes have been described to assess spatial memory in rodents. 
Among them, the Morris Water Maze (MWM) is the most used paradigm 
(Sharma et al. 2010). 
 
Neurobiology of learning and memory 
 
Non-declarative learning, called emotional or associative learning, involves 
mainly the amygdala, but also the striatum and nucleus accumbens 
(Lombroso 2004). Declarative learning involves the hippocampus and other 
structures of the medial temporal lobe, although definitely storage seems to 
be located in the cortex (Morgado 2005). Neocortical associative areas send 
sensorial information to the parahippocampal and perirhinal cortices that in 
turn send aferences to the enthorinal cortex. The enthorinal cortex gives 
aferences to the hippocampal formation, which includes the dentate gyrus, 
CA1-CA4, and the subiculum. The subiculum gives information back to 
the enthorinal cortex, which sends it to the parahippocampal region and 
then to the associative areas again (Rudy 2009).  
 
Spatial navigation is a complex process that besides the hippocampus, 
involves several brain areas such as striatum, basal forebrain, cerebellum 
and neocortical areas. Many electrophysiological and lesion studies support 
the proposition that the hippocampus is a critical structure for this kind of 
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learning (D'Hooge et al. 2001). O’Keefe and Nadel suggested that the 
hippocampus creates a neural representation of the physical space, called 
cognitive map, observing that some hippocampal neurons (place cells) 
were firing when the rat was in a specific location (Eichenbaum et al. 
1999). Parietal cortex, whose cells provide information about head position 
and movement, seem to provide additional information to the place cells 
(Ruiz-Medina 2007). It was shown that basal forebrain lesions impair the 
performance in the MWM, which is likely because it provides innervation 
to the hippocampus and neocortex. The striatum is implicated in the 
response flexibility, motor control and procedural consolidation in the 
MWM.  Cerebellum participates in the procedural aspects involved in the 
MWM task.  The prefrontal cortex also has a role in the MWM task to the 
extent that it allows the planning of movements required to solve the task, 
despite not having a proper role in memory (D'Hooge et al. 2001).  
 
Several neurotransmitter systems are related to the spatial learning and 
memory. The modulation of the cholinergic system has been shown to 
affect the performance in the MWM. The suppression of cholinergic 
activity by lesions or blocking muscarinic receptors impairs the acquisition 
of the task, but not the recall, but the administration of cholinergic agonists, 
by contrast, enhances learning in subjects with lesions and age-related 
deficits. The glutamatergic system is also related to the spatial learning, 
since the administration of receptor antagonists affects the MWM 
performance. However, research on glutamate implication is controversial. 
On one hand, NMDA may contribute to some aspects of the task, but on 
the other hand, it may not be essential for spatial learning. The amine 
system does not play a crucial role in spatial navigation, but noradrenaline, 
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dopamine and serotonin have been shown to affect different aspects of 
MWM performance in specific cases (Ruiz-Medina 2007).  
 
Assessment of memory and learning in rodents 
 
The Morris Water Maze (MWM) test was described in 1984 by Morris as a 
test to assess spatial learning and memory in rats. It is a circular pool in 
which there is a platform hidden 1 cm underwater. The water provides a 
spatial environment that avoids visible, audible and olfactory cues that may 
guide the animal to the target, and the animal must successfully navigate 
itself to it (Morris 2003). The MWM test has become one of the most 
frequently used tools in behavioural neuroscience, being used in 
neuropharmacological, neuropathological and physiological studies 
including aging (Patil et al. 2009). In addition, MWM has been used for the 
validation of rodent models for several neurocognitive disorders (D'Hooge 
et al. 2001). 
 
Many diverse protocols and tasks have been developed in the MWM in 
order to assess different aspects involved in the task or different kinds of 
learning. Cued or visible platform tasks have been developed to evaluate 
the motivation to escape or any visual disabilities that might affect the 
MWM performance. Reversal tasks change the position of the platform 
once the animal has learned the previous location, in order to assess 
cognitive flexibility to new learning. Working memory is also assessed in 
the MWM, by changing the position of the platform in each session. Latent 
learning tasks place the animal in the platform before the training trial, 
instead of after. In the standard reference memory task the animal must 
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learn to navigate to the hidden platform using distal cues (Vorhees et al. 
2006). Rodents can use different strategies to locate the escape platform; a 
praxic strategy, in which the animal learns the sequence of movements 
required to reach the platform, a taxic strategy, in which the animal uses 
proximal cues to reach the platform, or a spatial strategy, in which the 
animal reaches the target using information about the spatial location of the 
platform according to the spatial configuration of distal cues (D'Hooge et 
al. 2001; Sharma et al. 2010). To prevent the animal using internal or 
proximal cues, each trial starts from one of four different positions. 
However non-controlled proximal cues, for example irregularities in the 
wall of the pool, can supply additional information to the animal finding 
the platform. With the aim of avoiding those uncontrolled proximal cues, in 
our laboratory we added an inner rotating wall to the device, which rotates 
during each trial. This modification to the Water Maze has proven to be 
sensitive to detecting differences between Tg 2576 and wild type mice at 
early stages (Ribes et al. 2008). 
 
Despite the reliability of the test having been widely tested, characteristics 
of the animals, the apparatus features, the protocol used to train the animals 
and the quantification of data might all influence the performance in the 
task. Stable variables, such as gender or strain of the animals can lead to 
differences in performance in the MWM, and so should be taken into 
account. Environmental factors affecting the animal such as stress, 
undernourishment, sickness or age, can all impair performance in the 
MWM (D'Hooge et al. 2001). Furthermore, differences in the apparatus or 
training procedure, like the number of  trials per day, the location of extra-
maze cues, or the control of the intra-maze cues can either increase o 
decrease the sensitivity and the specificity for this test (Ribes et al. 2008).  
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4.3 Anxiety and memory systems interaction 
 
There is evidence coming from neurogenetics, neurochemistry, and 
behavioural pharmacology of interaction between memory and anxiety 
processes and that this interplay is an essential feature of CNS functioning. 
Memory consolidation and anxiety both require arousal (Kalueff 2007). 
The relationship between learning and stress has been shown to be non-
linear, whereas an inverted U function, in which memory increases with 
stress to an optimal point and then decreases, reflects this relationship in 
greater measure (Kalueff 2007; Salehi et al. 2010). A spatial learning test 







C.  Corticosterone levels increased as the temperature decreased but the 
best performance was shown for the group training at 19
o
C. This 
experiment highlights that certain level of stress is beneficial for learning 
(Salehi et al. 2010). 
 
The interaction between memory and anxiety has to be taken in account 
since performance of a mouse in a learning test can be affected by 
emotional states. Thigmotaxis behaviour in the MWM is considered an 
effect of high levels of anxiety that leads to poor performance. An 
inaccurate analysis can lead to confusion between increased anxiety states 
and poor spatial learning capacity. Water is stressful for rodents, and land 
tests, such as the T-maze and the Barnes maze, have been shown to be 
more appropriate for evaluating spatial learning in some mouse strains 
(Branchi et al. 2004; Sharma et al. 2010).  
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The presence in the environment of chemicals with probable toxic 
effect increases year on year. The possible effect of these substances on 
human health is unknown in many cases because of the difficulty and the 
cost of testing all the new chemicals appearing in the market. Detectable 
levels of Polybrominated diphenyl ethers (PBDEs) are found in wildlife 
and human samples, such as breast milk. European legislation forbade the 
use of lower brominated forms of PBDEs, which implied an increase in the 
use of higher brominated forms, such as the Decabromodiphenyl ether 
(BDE-209). Data reveals that BDE-209 levels in the environment have 
risen in recent decades. Babies are exposed to PBDEs during pregnancy, 
after birth through breast milk intake and by dust inhalation when toddlers. 
Children are vulnerable to toxicity due to their physical characteristics - 
lower body weight, less excretion capacity and so forth – and to the nature 
of development. Particularly, the CNS is especially susceptible to toxic 
damage during development (Henck 2002) showing both short term effects 
in youth but also long lasting effects. In recent years there has been an 
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increasing interest in identifying developmental exposure that modifies 
adult vulnerability to neurodegeneration or other disorders. There is little 
data available on the developmental and long lasting effects of perinatal 
BDE-209 exposure and less is known about the interaction of toxic 
exposure with other genetic risk factors. Regarding this, human 
polymorphisms for ApoE have shown to confer different vulnerability to 
neurodegeneration; being a carrier of ApoE4 allele is a risk factor to 
developing Alzheimer’s disease and provides more vulnerability to CNS 
damage. The aim of this study is to provide information about the possible 
short, middle and long term effects of an early BDE-209 exposure in a 
rodent ApoE model carrying the three human isoforms (ApoE2, ApoE3 and 
ApoE4), which are known to confer different vulnerability to develop 




The research hypothesis was as follows: 
 
The exposure to BDE-209 during the development stage produces mild 
alterations in the CNS. There is evidence of alterations in learning and 
memory or anxiety related behaviours in adulthood or in ageing when the 
compensatory capacity of the CNS decreases. The effects produced by 
early BDE-209 exposure interact with the ApoE genotype, the ApoE4 
group being the most vulnerable to the injuries.  
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2. Objectives 
  
2.1 General objective 
 
The main purpose of this research was to assess short, middle and long 
term neurobehavioural effects of early exposure to BDE-209 in ApoE2, 
ApoE3 and ApoE4 transgenic mice with distinct vulnerability to the 
development of neurodegenerative disease, and to evaluate possible effects 
of the interaction between the genotype, the treatment and gender. Three 
experimental phases were designed in order to address the objective.   
 
2.2 Specific objectives 
 
 
Experimental Phase I: Development 
 
The general objective of the first experimental phase was to characterize 
postnatal maturation of mice carrying one of the three ApoE 
polymorphisms and to study the possible interactions of early exposure to 
BDE-209, the ApoE genotype in the neuromotor and the physical 
development of transgenic ApoE mice. 
 
The specific objectives were as follows: 
 
 To evaluate genotype different parameters of physical, functional 
and neuromotor maturation during the postnatal period (PND1-
PND9) in each ApoE, 
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 To evaluate the effects of exposure to BDE-209 and its interaction 
with the ApoE genotype during the postnatal period on physical, 
functional and neuromotor maturation (PND11-PND40), and 
 To evaluate possible alterations in the myeliniation pattern derived 
from exposure to BDE-209 and its interaction with the ApoE 
genotype during the postnatal period (PND20). 
 
 
Experimental Phase II: 4 months old 
 
The general objective of the second experimental phase was to evaluate 
neurobehavioural effects of the oral administration of 0, 10 or 30 mg/kg of 
BDE-209 on PND10 in young adult ApoE2, ApoE3 and ApoE4 transgenic 
mice.  
 
The specific objectives were as follows: 
 
 To assess anxiety and locomotor activity in an EZM. 
 To assess anxiety and locomotor activity in an OF test. 
 To assess spatial learning and memory in a MWM reference task. 
 To determine levels of the thyroid hormones triiodothyronine (T3), 
thyroxine (T4) and free thyroxine (FT4) in blood serum. 
 To determine levels of the growth factor BDNF and its receptor 
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Experimental Phase II: 12 months old 
 
The general objective of the third experimental phase was to evaluate the 
neurobehavioural effects of the oral administration of 0, 10 or 30 mg/kg of 
BDE-209 on PND10 in, 12 months old females ApoE2, ApoE3 and ApoE4 
transgenic mice.  
 
The specific objectives were as follows: 
 
 To assess anxiety and locomotor activity in an EZM. 
 To anssess anxiety and locomotor activity in an OF test. 
 To assess spatial learning and memory in an MWM reference task. 
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To conduct this study the APOE Targeted Replacement Mouse Model was 
used. APOE Targeted Replacement mice express the human ApoE protein 
at the same pattern and level as non-demented humans and keep intact the 
regulatory sequences required for modulate ApoE expression, which 
provide a perfect model to study the neurobiology of the human ApoE 
isoforms (Sullivan et al. 2004).  
 
Adult male and female APOE Targeted Replacement Mice homozygous for 
the three human alleles (ApoE2, ApoE3, and ApoE4) were obtained from 
Taconic (Taconic Europe, Lille Skensved, Denmark). After a quarantine 
period of 7 days, female mice were mated with males of the same 
genotype. When a pregnant female was detected it was individually housed 
and allowed to deliver and wean its offspring. The day of delivery was 
designated as postnatal day 0 (PND0), and thirty days after (PND30) the 
pups were separated from the mother and housed in plastic cages of 2-4 
animals of the same sex. The animal room was maintained at a temperature 
of 22±2 °C, a relative humidity of 50±10%, and a 12-h light/dark automatic 
light cycle (light: 0800–2000 h). All animals were allowed free access to 
food (Panlab rodent chow, Barcelona) and tap water. The use of animals 
and the experimental protocol were approved by the Animal Care and Use 
Committee of the “Rovira i Virgili” University (Tarragona, Spain). 
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2. Chemical compound 
 
The compound used for the study is DE-USC 209, a decabromodiphenyl 
ether (BDE-209) (technical) purchased in LGC Promochem (Barcelona, 
Spain) (IUPAC nomenclature: 2,2',3,3',4,4',5,5',6,6'-decabromodiphenyl 
ether). The compound was dissolved in corn oil and the concentrations 




At postnatal day 10 (PND10) the litters, were treated at doses of 0, 10 or 30 
mg/kg of BDE-209 dissolved in corn oil. The treatment was administered 
by a micro-pipette of 2-20µl as a single oral dose. The range of doses was 
chosen based on previously published data; the dose corresponds to an 
equimolar dose of that used in the lower brominated compounds (Eriksson 
et al. 2001).  
 
4. Experimental schedules 
 
4.1 Experimental Phase I: Development 
 
 
This study was conducted to determine the development timeline of the 
three ApoE genotypes and to detect possible effects of BDE-209 exposure 
in the development of the mice. Pregnant females were individually housed 
and checked once a day. The delivery day was designated as postnatal day 
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0 (PND0) and the number of living and dead pups was recorded. From 
PND1 to PND36, a battery of tests was administered in order to evaluate 
the maternal care, the growth and several physical, functional and 
neuromotor parameters. On PND20, two males in each group from 
different litters were sacrificed and the brains were collected to determine 
the myelin pattern by Immunohistochemistry. 
Behavioural assessment, animal disposal, sample collection and 
histological determinations are detailed in following sections. 
 
4.2 Experimental Phase II: 4 months old 
 
This study was conducted to evaluate neurobehavioural effects of early 
postnatal exposure to BDE-209 in young adult ApoE2, ApoE3 and ApoE4 
mice.  
At 4 months of age, ten animals for each sex, treatment and genotype were 
weighed and tested in an Elevated Zero Maze (EZM) and an Open-field 
(OF) in two consecutive days. Three days after, spatial learning and 
memory in a Morris Water Maze (MWM) were evaluated for two 
consecutive weeks.  
 
A group of undisturbed animals were used for biochemical determinations. 
At the age of 5-6 months, five animals for each sex, treatment and genotype 
were killed by decapitation, and blood and brain samples collected for 
thyroid hormone and BDNF determinations.  
 
Behavioural assessment, animal disposal, sample collection and 
biochemical determinations are detailed in following sections.  
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4.3  Experimental Phase III: 12 months old 
 
This study was conducted to evaluate neurobehavioural effects of early 
postnatal exposure to BDE-209 in old ApoE2, ApoE3 and ApoE4 female 
mice.  
At 12 months of age, ten females for each treatment and genotype were 
weighed and tested in an Elevated Zero Maze (EZM) and an Open-field 
(OF) in two consecutive days. Three days after, spatial learning and 
memory in a Morris Water Maze (MWM) were evaluated for two 
consecutive weeks. At the end of the study animals were 13 months old. 
The behavioural procedure and the data analysis are explained above.  
 
5.  Behavioural assessment 
 
5.1 Physical and functional assessment during development 
 
 
A battery of different tests was administered during the postnatal period in 
order to determine the development timeline for each group. These tests 
included maternal care evaluation, body weight monitoring and physical, 
functional and neuromotor assessment. The use of functional observation 
batteries to assess development has been extensively used in toxicology 
(Moser 2000; Fuentes et al. 2007).  
 
Pregnant females were individually housed and checked once a day. The 
delivery day was designated as postnatal day 0 (PND0) and the number of 
living and dead pups was recorded. The body weight of the pups was 
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recorded throughout the developmental period, on PND1, PND4, PND8, 
PND10, PND12, PND21 and PND30.  
 
A maternal care test was conducted on PND1 and PND3. The pups were 
separated from the dam for one minute and then returned to the homecage 
and the latency to collect the first pup and the time required by the dam to 
collect all of them were recorded. The quality of nest was also scored on 
PND1 and PND3 as follows (0= no nest 1 =some nest, but not distinct 2= 
nest obvious: all pup are not in the nest area, 3= well defined nest; all pups 
in the nest area.  
 
From PND3 to PND8 the incisor eruption and the pinna detachment were 
recorded for each pup. From PND5, surface-righting ability was timed in 
each pup until all of them got it in less than 2 seconds.  
 
On PND10 pups were orally treated with 0, 10, or 30 mg/kg of BDE-209 
dissolved in corn oil, but no tests were carried out.  
 
Eye opening was scored from PND12 to PND20 as follows (0= both eyes 
closed 1= more closed than open 2 = more open than closed 3 = both eyes 
open).  
 
From PND12, neuromotor development was also assessed; the pups were 
placed near the top on a vertical screen and pulled backward by a gentle 
pull on its tail. The resistance offered by the pup during the pull was 
recorded. The marks for tail pull reflex were given as follows: 0, the pup 
offers no resistance; 1, some resistance; 2, good resistance during part of 
the pull; and 3, good resistance during most of the pull. In order to test 
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geotaxis, cling and climb ability, the pups were placed near the bottom on a 
vertical screen and allowed to climb. The time that pups take to turn was 
recorded. The marks for cling skill were given as follows: 0, the pup falls 
off immediately; 1, falls within 15 s; 2, holds on 15 s but slips back, and 3, 
spends 15 s at higher or same position. The marks given for climb skill 
were: 0, the pup falls off immediately; 1, climbs a body length using only 
forepaws; 2, does not reach the half of the screen, and 3, climbs to the top 











From PND21, the testicle descent in males and the vaginal opening in 
females were checked. The marks for the testicle descent were given as 
follows: 0, no testicle presence; 1, testis detected pressing the abdomen; 2, 
extracorporeal location of testicles starts becoming evident; 3, testicles are 
detected at first sight. The vaginal opening in females was scored as 0, no 
opening; 1, vaginal opening.  
 
At PND30 the pups were separated of the dam, and males and females 
were housed separately.  
 
Figure 4. Neuromotor tests  
 
A) Surface righting. B) Geotaxis. C) Cling and climb.  
A B C
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Body weight 1, 4, 8, 10, 
12, 21, 30 
Weight (g) 
Maternal care 1,3 Latency to collect the first pup 
Time (s) required to collect all pups 
Nest quality 1,3 0= no nest; 1 =some nest, but not clear;  
2= nest obvious: all pup are not in the nest area;  




Incisor eruption 3-8 Presence/Absence 
Surface righting 5-12 Time (s) 
Eye opening 12-20 0= both eyes closed; 1= more closed than open;  
2 = more open than closed;  3 = both eyes open 
Tail pull reflex 12-20 0= no resistance; 1= some resistance;  
2=good resistance during part of the pull;  
 3=good resistance during most of the pull 
Geotaxis 12-20 Time (s) 
Cling ability 12-20 0= the pup falls off immediately;  
1=falls within 15 s; 2=holds on 15 s but slips back;  
3=spends 15 s at higher or same position 
Climb ability 12-20 0= the pup falls off immediately; 1=climbs a body length 
using only forepaws; 2= does not reach the half of the 
screen; 3= climbs to the top half of the screen 
Testicle descent 21-36 0=no testicle presence; 1= testis detected pressing the 
abdomen; 2=extracorporeal location of testicles starts 
becoming evident; 3= testicles are detected at first sight. 
Vaginal opening 21-36 Presence/Absence 
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5.2 Elevated Zero Maze test 
 
Anxiety responses and exploration activity were measured in an Elevated 
Zero Maze (EZM) for mice, which is a modification of the Elevated Plus 
Maze (EPM) model of anxiety for rodents. The circular shape of EZM 
provides two advantages over the EPM. Firstly, it avoids the ambiguity in 
interpretation of the time spent in the central zone of the EPM, and 
secondly, it allows uninterrupted exploration (Shepherd et al. 1994). The 
apparatus is a white annular metacrylate platform (internal diameter 350 
mm. external diameter 460 mm.) elevated 50 cm off the floor. The total 
distance of the pathway is 500 mm, separated into two opposite enclosed 
quadrants and two open. A white methacrylate wall of 160 mm in height 
surrounds the enclosed quadrants and the open arms have a 0.5 cm edge to 










Mice were placed in the open area at the beginning of the test and allowed 
to move freely around the maze for 5 min. Experimenters were placed 50 
cm from the maze, controlling the time and recording the animal behaviour. 
Parameters recorded were latency to the first enter into the closed area, the 
















Figure 5. Elevated Zero Maze test (EZM)  
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area, the number of head-dips from closed to open area, the number of 
rearings, the number of freezings, the number of groomings and the number 
of defecations.  
 
5.3 Open Field test 
 
General motor activity and behavioural responses to a new environment 
were measured in an Open Field apparatus, which is a 60 × 60 cm wooden 
square surrounded by a 50 cm-high wall. Two areas are virtually 
differentiated in the Open Field: the periphery (the area 10 cm from the 
wall) and the central area (the rest of the open-field). Mice were placed in 
the centre of the arena at the beginning of the test being allowed to move 
freely around the open-field and to explore the environment for 30 min. 
The path and movements of the animals were recorded by a video camera 
(Sony CCD-IRIS model) that was placed above the square. The video 
tracking program Etho-Vision© (Noldus Information Technologies, 
Wageningen, The Netherlands) was used to measure the total distance 
travelled, the time spent in each area, and the number of rearings as a 











Figure 6. Open Field test (OF)  
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5.4 Morris water maze reference memory task  
 
The Water Maze is in a circular tank (diameter: 1m, height: 60 cm), 
virtually divided in four quadrants. An escape platform of 10 cm diameter 
was located 1cm below the water surface in the target quadrant. To acquire 
the task (locate the hidden platform) the animals performed 2 trials per day, 
with a 60 min inter-trial interval, for ten days. During each trial, mice were 
allowed 90 s to find the hidden platform and had to remain on it for 30 s. If 
the animal failed to find the platform at this time, the experimenter then put 
it onto it. The starting position was changed for each trial, from four 
different positions; none of them were placed in the target quadrant. To 
avoid proximal cues and prevent egocentrical learning, an internal mobile 
wall was added to the maze, and the wall was rotated between trials. The 
retention of the task was assessed by four probe trials during acquisition, 
which consisted of a 60 s free swim without the escape platform. The probe 
trials were performed on acquisition days 3, 5, 8 and 10 before the training 
session. Seventy-two hours after the last training session, long-term 
retention of the task was again tested using the same procedure. Animal 
performance was video recorded, with the camera (Sony CCD-IRIS model) 
placed above the maze, and data was analysed by the video tracking 
program Etho-Vision© (Noldus Information Technologies, Wageningen, 
The Netherlands). The latency to find the escape platform, distance 
travelled, and swim velocity during the training sessions were measured. 
During the probe trials, total time spent in the target quadrant and time 
spent in other quadrants were analysed as a measure of unbiased recall for 
spatial memory.  
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6. Disposal of the animals and sample collection 
 
 
For the myelin determination, two males in each group from different 
litters were sacrificed on PND20. The pups were anaesthetised with 
ketamine/xylazine and perfused through the heart with 4% 
paraformaldheyde (PFA). Brains were removed and fixed overnight in 4% 
PFA at 4ºC.  Subsequently they were placed into 30% sucrose in 0.1 M PO4 
for 48h at 4ºC and then snap frozen in methibuthane and kept at -20ºC. 
 
For the thyroid hormone and BDNF determinations, mice were sacrificed 
by decapitation. Blood was collected in 5 ml tubes and brains were 
immediately removed, frozen in liquid nitrogen and stored at −80ºC. Blood 
was centrifuged at 4000 rpm for 30-40 min and the temperature was 

























Figure 7. Morris Water Maze test (MWM) 
 
MWM apparatus modified to control intra maze cues. 
UNIVERSITAT ROVIRA I VIRGILI 
NEUROBEHAVIOURAL EFFECTS ASSOCIATED WITH POSTNATAL EXPOSURE TO DECABROMODIPHENYL ETHER IN APOE2, 
APOE3 AND APOE4 TRANSGENIC MICE 
Ingrid Reverté Soler 
DL:T. 162-2012 
             Material and Methods 
       -  - 90 
7. Myelin Basic Protein (MBP) Immunohistochemistry 
 
The MBP Immunohistochemistry was performed according to the methods 
described previously (Franco-Pons et al. 2006; Fuentes et al. 2007). For 
myelin basic protein (MBP) immunostaining, free-floating 40µm coronal 
sections of brain were rinsed in PBS and H2O2 to inactivate endogenous 
peroxidase activity. Sections were blocked in 10% goat serum (GS)–PBS 
0.5% Triton X-100 buffer (Sigma-Aldrich, Barcelona, Spain) for 2-3 h. 
Antibody against MBP (Chemicon, Barcelona, Spain) was diluted at 
1/1000 in blocking buffer and incubated for 48 hours at 4ºC. Tissue 
sections were then washed in PBS 0.5% Triton X-100 buffer and incubated 
with 1:200 biotinylated goat anti-rabbit antibody for 1 h at 37ºC. After 
additional washes, the secondary antibody was detected using the avidin–
biotin complex reaction (ABC Elite Kit, Vector Laboratories, Barcelona, 
Spain) and developed with peroxidase substrate kit DAB, SK-4100 (Vector 
Laboratories, Barcelona, Spain). The sections were dehydrated with 70%, 
96%, 100% ethanol and xylene, and mounted with DPX. 
 
8. Biochemical determinations 
 
 
8.1 Thyroid hormones determination in blood 
 
 
Thyroid hormones in serum were determined in ICS Camp de Tarragona 
Laboratory (Hospital Joan XXIII- Departament de Ciencies Mediques 
Basiques, URV). Triiodothyronine (T3), thyroxin (T4) and free thyroxin 
(FT4) levels were determined in blood serum by a chemiluminiscent 
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immunoassay (CLIA) (commercial methods and reactives Advia Centaur. 
Siemens). In this competitive immunoassay, the hormone competes with 
the one that is linked covalently to paramagnetic particles of the solid 
phase, for a limited amount of mouse monoclonal antibody against the 
hormone. The antibody is marked with a luminescent reactive. After the 
automatic dispensations and the incubation time, the final equilibrium of 
the reaction Ag-Ac is achieved. The system detects the quantity of lighting 
units, which is inversely related with the amount of hormone of the sample 
(Alonso et al. 2010).  
 
8.2 BDNF determination 
 
BDNF determination was carried on in the Neurobiology Research Unit, 
Rigshospitalet, Copenhagen University Hospital (Denmark). The growth 
factor BDNF and its receptor TrkB were determined in the hippocampus of 
ApoE2, ApoE3 and ApoE4 male mice treated with 0 or 30 mg/kg BDE-
209.  After decapitation, the brain was quickly removed and frozen in 
liquid nitrogen. Hippocampus and frontal cortex were dissected out, 
homogenized and sonicated in ice-cold protein extraction buffer (Pierce, 
Rockford, IL) containing protein inhibitor cocktail and sodium 
orthovanadate (Sigma). The protein concentration was measured with 
modified Lowry method (DC Protein Assay, BioRad Laboratories, Herlev, 
Denmark). Samples were protein-matched and dissolved in 2 x SDS 
(sodium dodecyl sulphate) sample buffer (125 mM Tris-HCl, pH 6.8, 4% 
SDS, 20% glycerol, 10% 2-mercaptoethanol), heated for 5 min, 100 °C and 
run on AnyKd SDS-polyacrylamide gel (BioRad) (60 minutes, 150 V, RT). 
The proteins were transferred onto a PVDF membrane (350 mA, 60 min, 
using cooled wet transfer, BioRad) and the membrane was blocked for 
UNIVERSITAT ROVIRA I VIRGILI 
NEUROBEHAVIOURAL EFFECTS ASSOCIATED WITH POSTNATAL EXPOSURE TO DECABROMODIPHENYL ETHER IN APOE2, 
APOE3 AND APOE4 TRANSGENIC MICE 
Ingrid Reverté Soler 
DL:T. 162-2012 
             Material and Methods 
       -  - 92 
unspecific binding with 5% non-fat dry milk (1 h, RT) and then incubated 
overnight at 4°C with either primary antibody (GAPDH, 1:50.000, 
MAB374, Millipore, MA; BDNF, 1:1000, sc-546, Santa Cruz, CA; TrkB, 
1:1000, #610101, BD Biosciences, NJ) Washed 3×10 min in TBS, blocked 
with 5% BSA in TBS for 1 h at room temperature (RT), incubated with 
horseradish peroxidase-linked secondary antibody (GαM or GαR, DAKO 
Cytomation, Glostrup, Denmark) diluted at 1:2000 in blocking solution for 
1 h at RT, and finally developed with ECL detection kit (Amersham 
Biosciences, RPN2106PL). Band intensity was quantified using the 
Quantity One software (BioRad). For each sample, the optical density of 
each band was normalized by dividing with the optical density of the 
corresponding band of GAPDH. 
 
9. Statistical analyses 
 
Data were analyzed by the SPSS Statistics 17.0 software. A three-way 
analysis of the variance (ANOVA) was performed using the genotype, the 
treatment and sex as main factors. Repeated measures multivariate analysis 
of variance with day or period of time as the within-subject factor was also 
used when appropriate. Post-hoc Tukey tests were used to analyze 
differences between groups. Analyses of variance homogeneity using a 
Levenne test were performed and non-parametrical Kruskal–Wallis test and 
Mann–Whitney U test were used when appropriate. Significance was set at 
p<0.05. 
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The evaluation of the effects of the early postnatal BDE-209 
exposure was carried out in ApoE targeted replacement mice – ApoE2, 
ApoE3 and ApoE4 – which have distinct vulnerability to develop 
neurodegenerative impairment with age. The research was divided in three 
experimental phases; Experimental Phase I: Development, Experimental 
Phase II: 4 months of age and Experimental Phase III: 12 months of age. 
Different animals were used in each experimental phase.  
 
In the first phase ApoE2, ApoE3 and ApoE4 pups were evaluated during 
the development period, before of the BDE-209 exposure from PND1 to 
PND9 and after BDE-209 administration from PND11 to PND36. On 
PND20 two males of each group from different litters were killed and their 
brains were removed to determine the myelin pattern.  
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In the second experimental phase ApoE2, ApoE3 and ApoE4 mice exposed 
on PND10 to a single oral dose of 0, 10 or 30 mg/kg BDE-209 were 
evaluated at 4 months old. Anxiety and activity were assessed in an EZM 
and an OF tests. Spatial learning and memory were assessed in a MWM 
memory reference task. At 5-6 months old, undisturbed animals were 
disposed by decapitation and blood and brains collected to determine 
thyroid hormones and BDNF respectively.  
 
In the third experimental phase ApoE2, ApoE3 and ApoE4 female mice 
exposed on PND10 to a single oral dose of 0, 10 or 30 mg/kg BDE-209 
were evaluated at 12 months old. Anxiety and locomotor activity were 
assessed in an EZM and an OF tests. Spatial learning and memory were 
assessed in a MWM memory reference task. 
 
In the current chapter you will find the results and discussion of each 
Experimental Phase.  
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1. Experimental Phase I: Development 
 
The first Experimental Phase comprised neurodevelopmental assessment of 
the ApoE transgenic mice from birth to early adulthood. We administered a 
battery of tests to assess litter characteristics, maternal care, and physical, 
functional and neuromotor development of the pups, before and after the 
BDE-209 treatment on PND10. In the analyses, the litter was taken as the 
study unit, and both sexes were evaluated separately. The results of 
Experimental Phase I: Development are explained in the following pages, 
organized as follows: Litter features, Maternal care, Physical development, 
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1.1 Results of the Experimental Phase I: Development  
 
 Litter features  
 
The litter size, the ratio of male pups and pup mortality were analyzed by a 
one-way ANOVA with the ApoE genotype as factor. As the litter size did 
not show variance homogeneity, a non-parametrical Kruskal-Wallis test 
was used for this variable. An effect of the genotype was significant in the 
litter size [X
2
=12.128, p=0.002], which was significantly smaller in ApoE4 
compared to the other genotypes. No effect of the genotype was found in 
male ratio or pup mortality (Figure I.1). Litters found with all pups dead 
shortly after birth were: one litter in ApoE3 (10 pups) dead on PND3, one 
litter in ApoE4 (8 pups) dead on PND1 and another litter in ApoE4 (2 
pups) dead on PND2.  None of them were included in the statistical 
analyses and complete data of pup mortality is detailed in Table 2.  
In brief, the litter size at birth depends on the genotype. In the ApoE4 
genotype the size of the offspring is reduced but maintains the sex ratio and 
mortality is similar in all the genotypes.   
 
Table 3: Neonatal mortality 
 
  
 Pups (litter) Total number of litters 
ApoE2 7 (6) 11 
ApoE3 17 (9) 20 
ApoE4 11 (4) 10 
Table 3. Distribution of dead pups among genotypes, number of litters affected and 
total number of litters studied.  
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To analyze the quality of maternal care the dam provides to the litter, a 
one-way ANOVA using the genotype as factor, was performed on the nest 
score, the latency (s) to collect the first pup and the time spent (s) on 
collecting and grouping all the pups in the nest area (corrected for the 
number of pups in each litter), on postnatal days 1 and 3. The effect of the 
genotype was not statistically significant in any of the measures and the 
nest did not score less than the maximum in any of the litters studied. A 
one-way ANOVA for repeated measures was also carried out on maternal 
care variables on PND1 and PND3. A decrease in the time to collect the 
pups from PND1 to PND3 was observed [F(1,40)=8.099,p=0.007] and an 
effect of the genotype [F(2,40)=6.710,p=0.003] was found. A paired t-test 
between maternal performance on day 1 and 3 showed that ApoE2 and 
Figure I.1. Litter features 
 
Number of alive (A), dead (B) and male pups/total pups (C) on PND0. Data are 
expressed as mean and S.E.M. Groups showing different letters a,b differ from each 
other at p < 0.05. The dashed line shows the theoretical expected male ratio.  
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ApoE3 mothers significantly decreased the time to collect the pups in 
PND3, while the mothers ApoE4 did not (Figure I.2). The maternal care 
quality was quite good in mothers of all the genotypes, but ApoE2 and 
ApoE3 mothers improved their efficiency during the first days, while 









Early growth (PND1-PND10) 
 
To analyze the growth of the animals, the litter median of body weight (g) 
was analyzed by a two-way ANOVA (genotype x sex) for repeated 
measures on postnatal days 1, 4, 8 and 10. The body weight increased 
significantly by the day [F(3,40)=641.359, p<0.001] and genotype and sex 
did not show any significant effect or interaction (Figure I.3). The day at 
Figure I.2. Maternal care 
 
Latency to collect the first pup (A) and time spent to collect and joint all the pups in the 
nest area (corrected for the number of pups of the litter) (B). Data expressed as mean and 
S.E.M. Variables showing an asterisk are different from each other at p < 0.05.  
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pinna detachment and incisor eruption were analyzed by a two-way 
ANOVA (genotype x sex). No effects of genotype, sex or interactions were 
statistically significant. All the animals presented detached pinna and 






Post-treatment growth (PND12-PND30) 
 
To detect possible effects of the treatment on the growth, a three-way 
ANOVA (genotype x treatment x sex) for repeated measures was 
performed on the litter median body weight recorded on PND 12, 21 and 
30. As expected body weight increased significantly during the period 
[F(2,40)=746.258, p<0.001]. An effect of the genotype [F(2,40)=4.336, 
p=0.017] was significant, indicating differences between ApoE4 and the 
other genotypes (Figure I.4).  
Figure I.3. Early growth 
 
Body weight at PND 1, 4, 8 and 10. Data are expressed as mean and S.E.M.  
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Additionally, an overall effect of the treatment [F(2,40)=3.547, p=0.035] is 
shown in Figure I.5. Interaction between the PND and the genotype 
[F(4,40)=7.049, p=0.002], the PND and the treatment [F(4,40)=4.131, 
p=0.021] and the PND, the genotype and the treatment [F(6,40)=2.566, 
p=0.047] were also significant, indicating different growth patterns 
depending on the genotype and the treatment. Therefore the analysis of 
post-treatment body weight change was carried out in each genotype 
separately by a two-way ANOVA (treatment x sex) for repeated measures. 
An effect of the treatment [F(2,10)=11.236, p=0.01] (Figure I.6) and an 
interaction between the PND and the treatment [F(3,10)=4.007, p=0.04] 
were observed in ApoE2 body weight. No effects of treatment or sex were 
observed in ApoE3 and ApoE4 mice.  
Figure I.4. Post-treatment growth by genotype 
 
Body weight at PND 12, 21 and 30. Data expressed as mean and S.E.M. 
ApoE4 genotype differs from ApoE2 (*) and from ApoE3 (#) at p<0.05. 
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Eye opening was scored from 0 to 3 from PND12 to PND2 and was 
analyzed by a three-way ANOVA (genotype x treatment x sex) for repeated 
measures. An effect of the day was found in the eye-opening score 
[F(9,40)=2128.657, p<0.001], and an interaction between the genotype and 
the treatment was statistically significant [F(4,40)=2.998, p=0.025]. Hence 
the analysis of eye opening was performed separately in each genotype by 
a two-way ANOVA (treatment x sex). An effect of the treatment was 
significant in ApoE2 group, showing a delay in eye opening in high dose 
exposed mice (Figure I.7). 
To summarize, early growth does not differ between genotypes, but ApoE4 
showed a smaller increase in body weight compared to the other genotypes 
from PND21. The 30 mg/kg BDE-209 treatment significantly reduced body 
weight and delayed eye opening in ApoE2 genotype.  
Figure I.5. Post-treatment growth by treatment  
 
Body weight (g) registered at PND 12, 21 and 30. Data are expressed as 
mean and S.E.M. The asterisk indicates a trend of difference between 
the control and high dose exposed group (p<0.065). 
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Figure I.6. Post-treatment growth by genotype and treatment 
 
Body weight (g) registered at PND 12, 21 and 30. Data are expressed as 
mean and S.E.M. High dose exposed mice differ from the control (*) 
and from both the control and the low dose exposed (#), at p<0.05.  
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Figure I.7. Physical development by genotype and treatment  
 
Eye opening score at PND 12,21 and 30. Data are expressed as mean 
and S.E.M. The asterisk indicates the high dose exposed mice differ 
from the control and the low dose exposed group at p<0.05.  
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Neuromotor development 
 
Several tests were carried out to assess the effects of the genotype, the 
treatment and the sex on the neuromotor development. For all variables 
studied, the litter has been used as the unit of analysis. 
 
Motor reflexes  
 
Surface righting was analyzed by a two-way ANOVA (genotype x sex) for 
repeated measures. The day at testing (PND5 -13) was taken as the within-
subject factor, while the dependent variable was the time (s) required for 
the pups to turn from the supine position to all fours. Surface righting in 
PND11, 12 and 13 was also analyzed by a three-way ANOVA (genotype x 
treatment x sex) to detect any possible effect of the BDE-209 administered 
at PND10. As expected, all the animals improved their ability over the days 
[F(7,40)=61.052, p<0.001] to acquire the ability to turn in less than two 
seconds on about PND11. No effects of genotype, sex or treatment were 
statistically significant.  
 
Geotaxis was analyzed by a three-way ANOVA (genotype x treatment x 
sex) for repeated measures. The day of testing (PND12 -16) was taken as 
the within-subject factor, while the dependent variable was the time (s) 
required for the pup to turn up when placed in front of a cliff. A significant 
effect of the day was found in geotaxis [F(4,40)=14.647, p<0.001]. An 
overall effect of the treatment [F(2,40)=3.323, p=0.043] was observed, but 
the post-hoc analyses did not show any differences between groups. 
Moreover, an overall effect of sex [F(1,40)=7.270, p=0.009] and an 
interaction between sex and genotype [F(3,40)=4.602, p=0.014] were 
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observed. The analysis of geotaxis conducted split by sexes showed an 










The resistance offered by the pup when pulled by the tail (tail pull test), the 
ability of the pup to hold onto a grid inclined at 45 degrees (cling test), and 
the ability of the pup to climb the mentioned grid (climb test), were tested 
from PND12 to PND21. Motor skills tests were analyzed by a three-way 
ANOVA (genotype x treatment x sex) for repeated measures taken as the 
within-subject factor on the day of testing, and the mean score of litter pups 
as a dependent variable in each test. 
Figure I.8. Negative geotaxis by sex and genotype 
 
Mean of time the pups took to turn up when placed in front of a cliff. Data are 
expressed as mean and S.E.M. The litter is the unit of analyisis. The symbol 
& indicates differences between ApoE4 and the other genotypes at p<0.05. 
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Results in the tail pull test showed that the animals improved as time went 
on [F(9,40)=237.369, p<0.001]. An effect of the genotype [F(2,40)=4.334, 
p=0.017] and an interaction between the genotype and the treatment 
[F(4,40)=3.067, p=0.023] were found to influence the test score. This 
interaction was studied by analyzing each genotype separately by a two-
way ANOVA (treatment x sex), which showed ApoE2 was the only group 







Results of the cling test showed that all the animals improved over time 
[F(6,40)=80.429, p<0.001]. An overall effect of the genotype 
[F(2,40)=5.466, p=0.006] and an overall effect of the sex [F(2,40)=5.829, 
p=0.019] were observed (Figure I.11). Moreover, trends towards treatment 
effects [F(2,40)=3.117, p=0.051] and interactions between the genotype 
and treatment [F(4,40)=2.273, p=0.071] justified a more detailed analysis.  
Figure I.9. Tail pull test by genotype 
 
Mean of tail pull score of the litter. Data are expressed as mean and S.E.M. The 
symbol & indicate differences between ApoE4 and the other genotypes at p<0.05.  
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Figure I.10. Tail pull test by genotype and treatment 
 
Mean of tail pull score of the litter. Data are expressed as mean and S.E.M. High 
dose exposed animals differ from control group (*) and both control and low dose 
exposed groups (#) at p<0.05. 
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Cling test performance was analyzed separately in each group (genotype 
and sex) to determine differential effects of the treatment. Results showed 
the BDE-209 treatment effects are evident in ApoE2 males [F(2,11)=5.050, 
p=0.038] and there is also a trend towards a treatment effect in ApoE4 
females [F(4,9)=4.321, p=0.069] (Figure I.12). The high variability 






Figure I.11. Cling test  
 
(A) Mean cling score in each genotype. (B) Mean of cling score in each 
sex. Data are expressed as mean and S.E.M. ApoE4 differ from ApoE2 (*) 
and from the other two genotypes (&) at p<0.05.  
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Figure I.12. Cling test by genotype, treatment and sex 
 
Data are expressed as mean and S.E.M. The asterisk indicates the high dose exposed 
ApoE2 mice differ from their control, and # indicates the high dose exposed ApoE2 mice 
differ from control and low dose exposed ApoE2 mice, at p<0.05. 
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Climb ability improved over time [F(9,40)=153.865, p<0.001] in all the 
groups. An overall effect of the treatment [F(2,40)=4.896, p=0.011] and an 
interaction between the treatment and the genotype [F(4,40)=5.100, 
p=0.001] were observed, indicating different maturation patterns depending 
on genotype and treatment. The analysis of the climb test carried out in 
each genotype separately by a two-way ANOVA (treatment x sex) for 
repeated measures, revealed a significant effect of treatment in ApoE2 mice 
(Figures I.13 and I.14).  
Taking all neuromotor data together, ApoE4 mice showed delayed negative 
geotaxis, tail pull and cling abilities. The BDE-209 treatment at high doses 








Figure I.13. Climb test by treatment  
 
Data are expressed as mean and S.E.M. The symbol (&) indicates control 
mice differ than treated, and (#) indicates differences between high dose 
exposed mice respect the other two groups at p<0.05.  
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Figure I.14. Climb test by genotype and treatment 
 
Data are expressed as mean and S.E.M. Groups showing different 
letters a, b, differ among them at p<0.05.  
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Post-weaning development: sexual maturation 
 
Testicle descent was scored in males from PND21 to PND 42 and analysed 
by a two-way ANOVA (genotype x treatment) for repeated measures, using 
the day of testing as the within-subject factor, and the score of testicle 
descent as dependent variable. An effect of genotype was observed 
[F(2,40)=3.085, p=0.044]. An effect of BDE-209 exposure appeared when 
the low and the high dose exposed groups were taken together 
[F(2,40)=4.752, p=0.037]. However, analyzing each genotype separately no 
significant effects between groups were observed (Figure I.15). 
 
 
Figure I.15. Sexual maturation  
 
Testicle descent by genotype (A) and by treatment (B). Data are expressed as mean 
and S.E.M. Symbols indicate differences at p<0.05 between; ApoE2 and the other 
genotypes (*), ApoE4 and ApoE3(#), control and BDE-209 exposed mice ($).  
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Vaginal opening day was checked in females from PND21 and analyed by 
a two way ANOVA (genotype x treatment) on the mean day at vaginal 
opening of the litter. Results did not show any significant effect of the 
genotype or the treatment. As in males, the effect of BDE-209 exposure 
(low dose and high dose exposed groups together) was examined and an 
effect of BDE-209 exposure in vaginal opening day [F(1,40)=5.448, 
p=0.026] and a trend towards an interaction between genotype and BDE-
209 exposure [F(2,40)=3.271, p=0.051] were observed. Analyzing this 
effect in each genotype separately, BDE-209 exposure showed a non 
significant trend in ApoE2 females [F(1,40)=4.008, p=0.08] (Figure I.16). 
 
In short, genotypes showed differences in the rhythm of sexual maturation 
in males; ApoE2 matures faster than ApoE4. BDE-209 exposure also 
delayed maturation in males, but did not affect differently the genotypes 
tested. Female sexual maturation was similar in all the genotypes, but the 
BDE-209 exposure affected the vaginal opening depending on the 





Figure I.16. Sexual maturation  
 
Vaginal opening day in control and BDE-209 exposed, ApoE2, ApoE3 
and ApoE4 female groups. Data are expressed as mean and S.E.M.  
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Myelination study 
 
During maturation and the myelination process, MBP is present in the 
cytoplasm of the soma and prolongations of the oligodendrocytes. As the 
myelination process advances, MBP localize in the membrane of the 
oligodendrocyte prolongations and myelin sheaths become compacted. 
Results for immunohistochemical MBP, performed at PND20 in males, 
were very similar between genotypes and the treatment effects were only 
evident in ApoE2 group.  
 
In Figures I.17 to I.20 the coronal sections show two medial sections 
including the hippocampal formation and striatal fibres, and an anterior 
section showing corpus callossum, fornix and anterior comissure.  
 
The MBP signal was present in all the sections stained, but a more intense 
and a more spread signal is compatible with a reduced compaction of the 
myelin sheaths in BDE-209 treated ApoE2 subjects compared to controls. 
Reduced compaction is visible in all sections, especially in the anterior one.  
This possible delay in myelination in ApoE2 is more evident in the anterior 
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Figure I.17. MBP immunostainning 
 
Coronal brain slices from ApoE2 male pups (PND20) administered 0 or 30 mg/kg BDE-
209 on PND10. Images show medial sections in which is observable the hippocampus 
formation (Hp), the striatum body (St) and the internal capsule (IC), consisting in 
descending cortical fibres. The enlargement allows distinguishing different parts of the 
hippocampus; CA1, CA2 and CA3 fields and dentate gyrus (DC).    
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Figure I.18. MBP immunostainning  
 
Coronal brain slices from ApoE2 male pups (PND20) administered 0 or 30 mg/kg 
BDE-209 on PND10 and a control adult. Images of medial sections show the 
hippocampus (Hp), the striatum body (St) and cortical fibres of the internal capsule 
(IC). The enlargement allows seeing in detail the anterior dorsal hippocampus.   
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Figure I.19. MBP immunostainning  
 
Coronal brain slices from ApoE2 male pups (PND20) administered 0 or 30 mg/kg BDE-
209 on PND10 and a control adult. Anterior sections show fibres of the corpus callossum 
(CC) connecting the hemispheres, the striatum (St), and ascending cortical fibres of the 
external capsule (EC). In the enlargement anterior commissure (AC) fibres travelling in 
the anterio-posterior direction are prominent as “spots” from the cross sectional cut. 
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Figure I.20. MBP immunostainning  
 
Coronal brain slices from PND20 male ApoE2 pups administered vehicle or 30 mg/kg 
DBDE on PND10. Images show enlargements of the anterior sections. In superior 
images are observable the interhemispheric fibres of the corpus callossum (CC) and the 
precommissural fornix (F), containing fibres from the hippocampus travelling to the 
septum and nucleus accumbens. In the inferior images the anterior commissure (AC) 
fibres are observable as two “spots” and the diffusely spread fibres of the 
precommissural fornix (F) in the midline.  
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1.2 Discussion of the Experimental Phase I: Development 
 
The developmental assessment of the ApoE transgenic mice exposed to 
BDE-209 on PND10 show that both factors, the ApoE genotype and 
postnatal exposure to BDE-209, influence developmental traits.  
 
Different ApoE genotypes showed differences in the size of the litter, 
maternal care, and physical and functional development of mice. 
Differences in development according to ApoE polymorphisms have not 
been previously studied in animal models, but there is some information 
available from humans. A study in Oregon found ApoE4 children carriers 
were ten times more likely to be placed in an Intensive Care Unit after birth 
and to have other pregnancy complications (Acevedo et al. 2010). In our 
study ApoE4 dams had fewer pups per litter and do not improve over time 
in their maternal care skills. However, ApoE4 pups did not show 
differences compared to the other genotypes in early development. Only a 
slight delay in body weight increase and a delay in the achievement of 
motor skills in late development were observed in ApoE4. There is no 
available data related to neurological development in humans carrying the 
different polymorphisms for the ApoE, but some studies investigate 
children’s performance in cognitive and behavioural traits related to the 
ApoE genotype. Alexander and coworkers assessed cognition in a 6- to 65-
year-old cohort and did not find association between ApoE genotype and 
brain function across the entire age range (Alexander et al. 2007).  
Similarly, a recent study failed to find any relationship between ApoE 
genotype and IQ, memory function or school attainment in children aged 7-
14 years (Taylor et al. 2011). On the other hand, Wright and colleagues 
observed better scores on the Bayley development scale in 2-year-old 
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children carrying ApoE4 (Wright et al. 2003) and Bloss and coworkers did 
not find any differences among genotypes in language or mathematical 
skills, but the ApoE2 genotype showed lower visuospatial scores (Bloss et 
al. 2010). Conversely, some studies found a positive association between 
the ApoE4 allele and lower cognitive execution. Impaired spatial memory 
retention was observed in children aged 7-11 years carrying the ApoE4 
allele (Acevedo et al. 2010), and  slower speed processing in children aged 
11 was reported by Luciano and colleagues (Luciano et al. 2009). 
Furthermore, ApoE4 carrier children have also shown reduced cortical 
thickness in the left enthorrinal cortex, while ApoE2 showed the thickest. 
ApoE4 cognitive deficits were also observed in children with other risk 
factors associated. Children carrying ApoE4 plus a family history of AD 
were also found to show lower cognitive scores (Bloss et al. 2008). 
Another study observed poorer memory scores correlated with the ApoE4 
allele and a specific BDNF genotype in children who had suffered a sexual 
trauma (Savitz et al. 2007). Likewise, a worse neurological outcome was 
found in ApoE4 children after a brain injury (Brichtova et al. 2008). Those 
studies suggest that in children the ApoE4 genotype may be associated with 
an impaired performance in specific abilities or under certain risk 
conditions. Our results show a slight delay in ApoE4 development, which 
does not implicate a severe impairment, since all the genotypes acquired all 
the development milestones assessed.  
 
Sexual development was also slightly delayed in ApoE4 male mice, but 
again no information is available, either in humans or animals, on sexual 
development and ApoE genotypes.  
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BDE-209 exposure showed to interact with ApoE genotype to exert its 
effects, since ApoE2, but not the other genotypes, was affected by the 
treatment. ApoE2 mice exposed to BDE-209 on PND10 showed decreased 
growth and delayed eye opening. In contrast, most studies do not find 
differences in pup body weight after perinatal PBDE exposure (Branchi et 
al. 2002; Zhou et al. 2002; Staskal et al. 2006; Tseng et al. 2006; Rice et al. 
2007; Kodavanti et al. 2011). There are two studies that have reported 
increases in body weight after neonatal PBDE exposure, which were not 
manifested in developing pups but became evident from one or two months 
of age (Dufault et al. 2005; Gee et al. 2008). These results would be in 
agreement with our findings, since ApoE2 exposed animals did not show 
decreased body weight until post-weaning period. However, there is a 
discrepancy, since pentaBDE showed body weight increasing while our 
animals exposed to the BDE-209 compound showed a decrease.  
 
Two studies attempted to relate ApoE genotype with the vulnerability to 
toxic insults in adult subjects, which found that ApoE4 allele was 
associated with higher lead and mercury body burdens and more persistent 
CNS toxic effects (Stewart et al. 2002; Godfrey et al. 2003). This 
relationship has been considered to be due to the diminished ability of 
ApoE4 to eliminate heavy metal (Mutter et al. 2004). On the other hand, 
one study found greater negative effects of Pb in the Development Index of 
the Bayley Scale in children carrying ApoE2 or ApoE3 compared to 
ApoE4 children. A strong association was found between ApoE levels and 
Pb in children, at levels of Pb exposure below the thresholds of concern 
established by regulatory agencies (Birdsall et al. 2010). Discrepancies 
between studies in lead toxicity could be related to the age at testing and to 
the levels of lead exposure, however they point to a relationship between 
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lead toxicity and the ApoE genotype. Some studies found a higher 
susceptibility for development disturbances after cardiac surgery in 
children who were ApoE2 carriers. These infants showed lower mental and 
psychomotor indexes at one year of age and lower growth and behavioural 
and social interaction problems at 4 years (Gaynor et al. 2003; Gaynor et al. 
2007; Gaynor et al. 2009; Burnham et al. 2010). Data previously reported 
suggest that ApoE2 might be more vulnerable during development after an 
environmental challenge. In the present study, ApoE2 mice exposed to 
BDE-209 showed delays in all neuromotor tests carried out and those 
detrimental effects were more pronounced in high dose exposed mice.  
Alterations in motor development have been already reported after PBDE 
exposure. Subtle affectation in coordination, grip time and inverted screen 
test from PND12-18 in C57BL/J6 mice exposed to BDE-47 has been 
reported (Gee et al. 2008), and delayed appearance of climbing ability was 
found in Swiss CD1 females exposed to 30 mg/kg of BDE-99 (Branchi et 
al. 2003). Neonatal exposure to BDE-209 did not show any motor 
retardation in C57BL/J6 mice, but there was an observed delay in palpebral 
reflex acquisition (Rice et al. 2007). 
 
Sexual development was also delayed in mice exposed to BDE-209 in the 
current study. In females, but not in males, this delay was also related to 
ApoE2 genotype. PentaBDE congener exposure has been shown previously 
to retard the onset of puberty in rodents of both sexes (Stoker et al. 2005; 
Lilienthal et al. 2006). 
 
The myelination pattern was also altered in ApoE2 mice exposed to 
30mg/kg of BDE-209. The myelination process occurs during BGS and any 
environmental interference during foetal and early life period could affect 
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myelin synthesis and compaction. Malnutrition during critical periods, such 
as iron or fatty acid deficiency, has been shown to alter myelination (Di 
Biase et al. 1997; Georgieff 2007) as well as exposure to toxic agents, for 
example the copper chelator cuprizone induces a severe brain 
demyelination (Pott et al. 2009). PBDE effects on myelination process have 
not been studied, but PBDE is recognized as thyroid hormone disruptor and 
hypothyroidism leads to delayed myelination (Dufault et al. 2005). The 
developing myelination process related to ApoE isoforms has not been 
explored either, but ApoE and cholesterol are known to play a critical role 
in myelin maintenance, integrity and recovery (Vila-Rodriguez et al.; 
Bartzokis et al. 2007; Li et al. 2010; Vila-Rodriguez et al. 2011). White 
matter relative to the ApoE genotype has been studied in healthy and 
demented adults, finding a correlation between diffused white matter, 
cognitive decline and presence of the Apoe4 allele (Nierenberg et al. 2005; 
Heise et al. 2010; Ryan et al. 2011). The altered pattern of myelination 
found in ApoE2 mice exposed to BDE-209 may be responsible for the 
delayed acquisition of neuromotor abilities observed. These results deserve 
more experimentation to explore possible effects or interactions between 
genotype, treatment and sex using semi-quantitative methods or electronic 
microscopy techniques.    
 
This research highlights that genetic factors, such as the ApoE genotype, 
influence development and modulate neurodevelopmental toxic effects 
induced by PBDEs. Moreover, the full-brominated BDE congener, which is 
supposed to be less toxic, appeared able to affect development in 
vulnerable subjects. 
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Taking these results together, ApoE2 can potentially be used as a risk 
biomarker for toxic exposures to PBDE during development. In this regard, 
this genotype has also been shown to be a risk factor to other toxic insults, 
such as Pb exposure as mentioned above. 
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2. Experimental Phase II: 4 months-old 
 
Experimental Phase II consisted in the evaluation of young adult ApoE 
transgenic mice exposed to BDE-209 on PND10. Anxiety and locomotor 
activity were assessed in an EZM and an OF. Spatial learning and memory 
were assessed in a MWM spatial reference task. The levels of thyroid 
hormones and the levels of BNDF in in the hippocampus of control and 
exposed ApoE mice were studied. The results of the second experimental 
phase are detailed in subsequent pages organized as follows: body weight, 
activity and anxiety measures in the Elevated Zero Maze and in the Open 
Field, learning and memory in the Morris Water Maze reference memory 
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Body weight (g) at 4 months of age was analyzed by a three-way ANOVA 
(genotype x treatment x sex). As was expected, males weighed more than 
females [F(1, 191) = 80.892, p<0.001]. An overall effect of the genotype 
[F(2, 191) = 9.681, p<0.001], an interaction between genotype and sex 
[F(2, 191) = 4.383, p=0.009] and an interaction between genotype and 
treatment [F(2, 191) = 4,161 p=0.017] were also observed. Genotype 
differences in body weight were restricted to females [F(2, 97) = 29.139, 






Figure II.1. Body weight at 4 months of age by genotype and sex  
 
Data are expressed as mean and S.E.M. Groups showing different letters a,b,c 
are different from each other at p < 0.05.  
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BDE-209 postnatal exposure affected body weight differently depending 
on both genotype and sex. Significant differences were observed in ApoE4 
males [F(2, 33) = 6.381, p=0.005], whose treated with BDE-209 showed a 
decrease in body weight, and in ApoE3 females [F(2, 31) = 3.718, 
p=0.037], of which those exposed to the low dose showed a slight increase 







Figure II.2. Body weight at 4 months of age by genotype, sex and        
treatment 
 
 Data are expressed as mean and S.E.M. Groups showing different letters a,b 
are significantly different from each other at p < 0.05.  
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To summarize, the female body weight is clearly affected by the genotype. 
The effects of BDE-209 treatment on PND10 remain in young adults 
depending on the genotype, effects which are evident in ApoE4 males and 
ApoE3 females.  
 
Elevated Zero Maze 
 
The evaluation of anxiety at four months of age was conducted in an EZM 
test. Ten animals were excluded from the analyses because they fell off the 
apparatus (Table 4).  
 














0 mg/kg 0 0 2 0 2 0 4 
10 mg/kg 0 0 1 1 0 0 2 
30 mg/kg 0 1 2 0 0 1 4 
 0 1 5 1 2 1  





The analysis of the EZM was conducted by a three-way ANOVA 
(genotype x treatment x sex) on the latency (s) to enter the closed area, the 
time (s) spent in the open area, the number of crossings from the closed to 
the open area, the number of head dips, rearing, grooming, freezing and 
defecation. A correction was made in the time (s) spent in the open area, by 
Table 4. Number of the animals removed from the statistical analyses because they fell 
off the EZM apparatus and its distribution among groups (genotype, treatment and 
sex). Data is expressed as absolute values.  
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subtracting the latency to enter the closed area from the total time spent in 
the open area. This correction was made in order to find a measure of the 
time the animals spent in the open area, when they crossed out voluntarily.  
 
As none of the variables, with the exception of the grooming, showed 
variance homogeneity, the non-parametrical Kruskall-Wallis test was used. 
Results showed an overall effect of the genotype in the latency [X
2
 = 
15.422, p<0.001], in the corrected time spent in the open area [X
2
 = 4.652, 
p<0.001], in the number of crossings [X
2
 = 63.107, p<0.001], in the 
number of head dips [X
2
 = 22.054, p<0.001], in the number of rearings in 
the closed area [X
2
 = 1.930, p=0.012], in the number of freezings [X
2
 = 
20.429, p<0.001]and in the number of defecations [X
2
 = 6.111, p=0.047] 
(Figure II.3). With respect to grooming behaviour, a significant interaction 
was observed between treatment and sex [F(2, 164) = 3,515, p=0.032], and 
there was a trend towards an interaction between sex and genotype [F(2, 
164) = 2,854, p=0.061], and between treatment, sex and genotype [F(4, 
164) = 2,134, p=0.079].  
 
ApoE4 showed an increased latency to enter the closed area, and thereafter 
made fewer crossings and spent less time in the open area (corrected time 
in open area) than the other genotypes. ApoE4 also did less rearing and 
head dips and displayed more freezing than the other genotypes.  
 
Additionally, we analyzed the effect of the treatment separately in each 
genotype and sex. An effect of the treatment in the number of crossings 
was observed in ApoE3 females [X
2
 = 6.383, p=0.041] (Figure II.4). 
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Figure II.3. Behavior in an EZM by genotype 
 
Data are expressed as mean and S.E.M. Groups showing different letters a,b,c 
are different from each other at p < 0.05.  
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Briefly, the analysis in the EZM showed a strong effect of the genotype in 
exploratory and anxiety-like behaviour measures of the test, the ApoE4 
mice being those more anxious and less active. The treatment showed only 
a slight effect in ApoE3 females, in which those exposed to the low dose 
showed an increase in the number of crossings to the open area. 
Figure II.4. Behaviour in the EZM by genotype, treatment and sex 
 
Number of times the animals crossed from the closed to the open area. Data are 
expressed as mean and S.E.M. Groups showing different letters a,b,c are 
significantly different from each other at p < 0.05.  
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Open Field  
 
General activity in the Open Field 
 
General activity was analyzed by a three-way ANOVA (genotype x 
treatment x sex) for repeated measures using six 5-min periods as the 
within-subject factor and the distance travelled as dependent variable. The 
period of time had a significant effect on the distance travelled [F(6, 181) = 
70.978, p<0.001]. All the animals shortened the distance travelled over 
time indicating habituation to the new space. An overall effect of the 
genotype [F(2, 181) = 29.308, p<0.001] and an interaction between the 





Figure II.5. Distance travelled in the OF by genotype 
 
 Data is expressed as mean and S.E.M. The symbol # indicates that all three 
genotypes differ among them; the asterisks indicate differences between ApoE2 and 
the other genotypes. p<0.05. 
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A three-way ANOVA (genotype x treatment x sex) was carried out on the 
total distance travelled and the total number of rearings. Since none of the 
variables showed variance homogeneity, the non-parametrical Kruskall-
Wallis test was used. An overall effect of the genotype was found in the 
total distance travelled (cm) [X
2
 = 63.272, p<0.001] and in the total number 
of rearings [X
2
 = 44.607, p<0.001]. The ApoE2 group travelled further than 
the other genotypes and reared more compared with ApoE4 (Figure II.6). A 
treatment x sex interaction was also significant in the total distance 







A more detailed analysis was carried out to assess the effects of the 
treatment in each genotype and sex for the distance travelled in each 5-min 
period. An overall effect of treatment was found in ApoE4 females [F(2, 
29) = 5.377, p<0.010] (Figure II.7).  
Figure II.5. General activity in the OF by genotype  
 
(A) Total distance travelled. (B) Total rearing performed. Data are expressed as 
mean and S.E.M. Groups showing different letters a,b,c  are different from each 
other at p < 0.05.  
UNIVERSITAT ROVIRA I VIRGILI 
NEUROBEHAVIOURAL EFFECTS ASSOCIATED WITH POSTNATAL EXPOSURE TO DECABROMODIPHENYL ETHER IN APOE2, 
APOE3 AND APOE4 TRANSGENIC MICE 
Ingrid Reverté Soler 
DL:T. 162-2012 
              Results of Experimental Phase II: 4 months old 






The treatment effects on the total distance travelled and the total rearing 
were also analyzed in each genotype and sex group. An overall effect of the 
treatment was found in the total number rearing in ApoE2 males [F(2, 29) 
= 3.552, p=0.043], in ApoE3 females [F(2, 29) = 3.835, p=0.034] and in 
Figure II.7. Distance travelled in the OF by genotype, sex and treatment 
 
Data are expressed as mean and S.E.M. The asterisk indicates differences between 
ApoE4 control and ApoE4 high dose exposed female mice at p < 0.05.  
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ApoE4 females [F(2, 30) = 3.686, p=0.037]. Total distance travelled was 
affected by the treatment in ApoE4 females [F(2, 30) = 5.377, p=0.010] 
(Figure II.8 and II.9).  
 
In general terms, the effect of the treatment is a reduced activity in females. 
This reduction is significant in ApoE4 females for both vertical and 
horizontal activity in the highest dose.  
Figure II.8. General activity in the OF by genotype, treatment and sex 
 
Total rearings performed. Data are expressed as mean and S.E.M. Groups showing 
different letters a,b,c are different from each other at p < 0.05.  
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Activity in the centre of the OF 
 
A three-way ANOVA (genotype x treatment x sex) was performed on the 
number of entries to the centre and the time (s) spent in the centre. In 
addition, a ratio of the rearings in the centre (rearing in the centre / total 
Figure II.9. General activity in the OF by genotype, treatment and sex 
 
Total distance travelled. Data are expressed as mean and S.E.M. Groups showing 
different letters a,b,c are different from each other at p < 0.05.  
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rearing) and a ratio of the distance travelled in the centre (distance in the 
centre/total distance) were calculated and analyzed. The ratio of distance 
travelled in the centre did not show variance homogeneity, so the non-
parametrical Kruskall-Wallis test was used for this variable. An overall 
effect of the genotype was found in the number of entries to the centre 
[F(2,181)=17.480, p<0.001], the time spent in the centre [F(2,181)=4.655, 
p=0.011] and the ratio of distance travelled in the centre [X
2
 = 15.393, 
p<0.001]. ApoE2 showed more entries to the centre, but ApoE3 spent more 
time and travelled more distance in the centre compared with the other 
genotypes. (Figure II.10). A treatment x sex interaction was found in the 
number of entries to the centre [F(3,181)=7.281, p=0.001].   
 
Figure II.10. Activity in the centre of the OF by genotype 
 
Number of entries (A) and time spent (B) in the centre. Ratio of rearing in the centre (C) 
and ratio of distance travelled in the centre (D). Data are expressed as mean and S.E.M. 
Groups showing different letters a,b,c are different from each other at p < 0.05.  
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The activity in the centre for each group (genotype and sex) was analyzed 
by a one-way ANOVA. The BDE-209 treatment affected exclusively the 
number of entries to the centre of ApoE4 females [F(2, 30) = 3.583, 






Figure II.11. Activity in the centre of the OF by genotype, treatment and sex 
 
Number of times the animals entered to the centre. Data are expressed as mean and S.E.M. 
Groups showing different letters a,b are different from each other at p < 0.05.  
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Summarizing, the results in the OF test indicate differences in exploratory 
behaviour profiles related to the ApoE genotype. ApoE2 mice showed 
higher general activity, while ApoE3 mice spent more time and explored 
the centre of the field more compared with mice of the other genotypes. 
ApoE4 mice showed the lowest activity in the entire field. The treatment 
increased the activity in ApoE2 males and decreased the activity in ApoE3 




Morris Water Maze reference memory task 
 
General analyses in the Acquisition of the MWM task 
 
To evaluate learning capacity we analyzed performance in each daily 
session during the ten days of the acquisition in the MWM task. Data was 
analyzed by a three-way ANOVA (genotype x treatment x sex) for repeated 
measures using the session as a within-subject factor, while the dependent 
variables were the escape latency (s), the distance travelled (cm) to get the 
platform, and the search velocity (cm/s). 
 
There was an effect of the session on the escape latency [F (9,191)= 
102.921, p<0.001] and on the distance travelled [F (9,191)= 166.241, 
p<0.001], which indicates that animals improved their performance over 
the acquisition days. There was also an effect of the session on the search 
velocity [F (9,191)=26.383, p<0.001], indicating changes in velocity 
through acquisition.  
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Multivariate analysis showed an interaction between session and genotype 
in escape latency [F (18,190)= 1.887, p=0.016], in distance travelled [F 
(18,190)= 2.108, p=0.006] and in search velocity [F (18,190)= 4.694, 
p<0.001]. An interaction between session and sex [F (9,191)= 2.971, 
p=0.003] and an interaction between session, treatment and sex [F 
(18,191)= 1.700, p=0.038] were also observed in the escape latency. An 
interaction between session, genotype and sex appeared in the distance 
travelled [F (18,191)= 1.639, p=0.049], and finally an interaction between 
session, genotype, treatment and sex was found on search velocity [F 
(36,191)= 1.671, p=0.009]. 
 
An overall effect of genotype was observed on the escape latency [F 
(2,191)= 34.127, p<0.001], on the distance travelled [F (2,191)= 23.227, 
p<0.001] and on velocity [F (2,191)= 74.803, p<0.001] (Figures II.12, 
II.13, II.14). An interaction between genotype and treatment [F (4,191)= 
3.514, p=0.009] affected the distance travelled. Velocity was also affected 
by sex [F (1,191) = 4.219, p=0.041]. 
 
General analyses showed a clear effect of the genotype in the task 
acquisition. The three genotypes differed among them in the escape latency 
and the search velocity. Moreover, ApoE3 mice travelled less distance than 
the mice of the other two genotypes (Figure II.12 D-F). Although genotype 
exerts a major effect on this task, the effect of sex and the interactions 
between genotype and treatment on the performance acquisition should 
also be taken in account. Because multiple interactive effects emerged, we 
carried out a more detailed analysis by gender genotype and treatment to 
better analyze differences between experimental groups. 
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Figure II.12. MWM acquisition by genotype 
 
Escape latency (A), distance travelled (B) and search velocity (C) and their mean of 
ten sessions respectively (D, E, F). Data are expressed as mean and S.E.M. Groups 
showing different letters a,b,c are different from each other at p < 0.05.  
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Gender Analyses on the acquisition of the MWM 
 
We analyzed the performance by sex during the ten daily acquisition 
sessions of the MWM in order to find out whether the genotype or the 
BDE-209 treatment can affect males or females in a different way. Data, 
separately by sex, was analyzed by a two-way ANOVA (genotype x 
treatment) for repeated measures using the session as a within-subject 
factor and the escape latency (s), the distance travelled (cm), and the search 
velocity (cm/s) as variables.  
 
As observed in the general analyses, both males and females improved over 
the sessions (p>0.001). The in-between subject analysis showed an effect 
of the genotype in both males and females for all the variables studied 
(p<0.001). ApoE4 males differed from the other two genotypes in escape 
latency, while in distance travelled ApoE3 males were who differed from 
the other genotypes, and the three genotypes were different in their search 
velocity among males. ApoE4 females differed from the other two 
genotypes in escape latency, ApoE3 females differed from the other 
genotypes in distance travelled, and the three genotypes were different in 
their search velocity among females. BDE-209 exposure affected 
acquisition in males, which was observed in distance travelled [F (2,93)= 
3.780, p=0.027] An interaction between genotype and treatment [F (2,93)= 
2.711, p=0.035] was also found in males.  
 
In summary, the acquisition performance was affected by the genotype in 
the same way in both males and females, which reflects the overall 
genotype effect found in the general analyses above. However, the BDE-
209 treatment effect is more evident in males.   
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Group Analyses on the acquisition of the MWM 
 
Previous analyses showed some interactions within the genotype, the sex 
and the treatment on the acquisition performance. We analyzed 
performance during the ten sessions of acquisition by genotype and sex in 
order to find any differential effects of BDE-209 effects by group. A one-
way ANOVA for repeated measures was carried out, using the session as a 
within-subject factor and the escape latency (s), the distance travelled (cm), 
and the search velocity (cm/s) as variables. 
 
An effect of the treatment on the escape latency was observed in ApoE3 
males [F (2,28)= 9.165, p=0.001]. An effect of the treatment on the 
distance travelled was found in both ApoE2 males [F (2,30)= 4.581, 
p=0.019] and ApoE3 males [F (2,28)= 4.241, p=0.025]. This result 
indicates that the effect of BDE-209 exposure found in ApoE2 and ApoE3 
is attributable only in males of both groups.  
 
In summary, only ApoE2 and ApoE3 males showed a general treatment 
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Figure II.13. MWM acquisition by genotype, sex and treatment 
 
Escape latency (A, B, C) and their mean of ten sessions (D, E, F). Data are expressed 
as mean and S.E.M. The asterisk indicates the high dose group differs from the 
respective control. Different letters a, b indicate differences between groups. p < 0.05.  
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 Figure II.14. MWM acquisition by genotype, sex and treatment 
 
Distance travelled (A, B, C) and its mean of ten sessions (D, E, F). Data are expressed 
as mean and S.E.M. The symbol (#) indicates differences between the high and the low 
dose groups. Different letters a, b indicate differences between groups. p < 0.05.  
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Figure II.15. MWM acquisition by genotype, sex and treatment 
 
Search velocity (A, B, C) and their mean of ten sessions (D, E, F). Data are 
expressed as mean and S.E.M.  
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General analyses on retention during the MWM task acquisition 
 
We analysed the retention ability in the probe trials carried out during the 
acquisition before the daily sessions on days 3, 5, 8 and 10, in order to find 
out whether progressive training affects the retention capacity and to find 
any effect of the genotype, treatment or sex. A three-way ANOVA 
(genotype x treatment x sex) for repeated measures was carried out, using 
the session as a within-subject factor and the time spent (s) in the target 
quadrant (Tgq) and the distance travelled (cm) in the Tgq as variables. As 
expected, there was a statistically significant effect of the session on the 
time spent in the Tgq [F (3,190)= 36,934, p<0.01] and the distance 
travelled in the Tgq [F (3,190)= 32.841, p<0.001]. An overall effect of 
genotype was found on the time spent in the Tgq [F (2,191)= 4,619, 
p=0.011] and on the distance travelled in the Tgq [F (2,191)= 39.266, 
p<0.001] (Figure II.16). No effects of the treatment or sex were observed. 
All the animals improved retention during the acquisition. ApoE3 showed 
better performance in the eighth session. ApoE4 travelled less distance in 
the Tgq compared to the other two genotypes in all probe trials (Figure 
II.16). 
 
Genotype and group analyses on the retention of the MWM   
 
As the genotype effect was significant in both acquisition and retention of 
the MWM task, we analysed separately the retention ability in each 
genotype using a two-way ANOVA (treatment x sex) for repeated 
measures.As observed in the general analysis, there was an effect of the 
probe trial in the time spent and the distance travelled in the Tgq (p<0.001) 
for all genotypes. No effects of treatment or sex were found in any of the 
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genotypes in the time spent in the Tgq, but an effect of treatment was 
observed in distance travelled in the Tgq in ApoE3 mice [F (2,60)= 3.160, 
p=0.05]. When analysing this effect in each group (genotype and sex), it 
was observed only in ApoE3 males [F (2,28)= 3.479, p=0.046], whom 
exposed to the high dose of BDE-209 differed from their controls. Main 




Figure II.16. MWM retention by genotype 
 
Time spent (A) and distance traveled (B) in the Tgq in each probe trial. Data are 
expressed as mean and S.E.M. Groups showing different letters a,b, or an asterisk are 
different from each other at p < 0.05. Dashed line indicates execution by chance.  
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Figure II.17. MWM retention by genotype, sex and treatment 
 
Time spent in the Tgq in each probe trial in sessions 3, 5, 8 and 10. Data are 
expressed as mean and S.E.M. The dashed line indicates execution by chance.  
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Figure II.18. MWM retention by genotype, sex and treatment 
 
Distance travelled in the Tgq in each probe trial in sessions 3, 5, 8 and 10. 
Data are expressed as mean and S.E.M.  
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In summary, performance of retention probes during acquisition sessions 
improve over time, as expected. Males obtain better scores than females in 
the ApoE2 and ApoE4 groups, although sex differences are only 
statistically significant for ApoE4 mice not exposed to BDE-209 in the last 
probe trial (p = 0.040). Treatment effects were limited to one of the 
genotypes tested, the ApoE3. 
 
Long-term retention of the MWM 
 
Long-term memory assessed in a probe trial carried out 72h after the last 
training session was analysed by a three-way ANOVA (genotype x 
treatment x sex) on the time spent and the distance travelled in the Tgq. An 
overall effect of genotype was found in the distance travelled in the Tgq [F 
(2,190)= 15.149, p<0.001]. A trend towards an interaction between 
genotype, treatment and sex was also observed in the distance travelled in 
the Tgq [F (4,190)= 2.404, p=0.052]. Nevertheless all the animals 
performed above the chance level.  
 
Figure II.19. Long-term retention in the MWM by genotype 
 
Time spent (A) and distance travelled (B) in the Tgq 72h after the last session. 
Groups showing different letters a,b are different from each other at p < 0.05. 
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The analysis of the long-term retention by group (genotype and sex), 
showed a treatment effect that appeared only in ApoE3 females in the time 
spent in Tgq [F (2,31)= 3.807, p=0.034] and in the distance travelled in the 
Tgq [F (2,31)= 5.205, p=0.012]; but post-hoc analyses failed to show any 




Figure II.20. Long-term retention in the MWM by genotype, 
treatment and sex  
 
Time spent in the target quadrant in the 72h probe trial. Data are expressed 
as mean and S.E.M. 
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Briefly, the ApoE4 genotype travelled less distance in the Tgq during the 
long-term retention probe trial, although the time spent searching for the 
platform in the Tgq is similar to the other genotypes. In general terms, 
treatment effects on long-term retention are isolated and showed high 




The level of thyroid hormones, T3 (nmol/L), T4 (nmol/L) and free FT4 
(pmol/L) was analysed by a three-way ANOVA (genotype x treatment x 
sex) on the quantity of T3 (nmol/L), on the quantity of T4 (nmol/L) and on 
the quantity of FT4 (pmol/L). Reference values for the forms analysed are: 
FT4 (10-20); T4 (58-140); T3 (0.9-2.8). 
 
An overall effect of genotype was found in T3 [(F (2,51) = 4.090, 
p=0.026)]. ApoE2 showed inferior levels of T3 compared with ApoE3 and 
ApoE4. No effects of the treatment or interactions were observed (Figure 
II.21).  
 
The effect of BDE-209 exposure on the hormones levels was analysed 
separately in each sex by a one-way ANOVA. No effect of the treatment 
was found, but using the BDE-209 exposure (control animals vs. animals 
exposed to low and high dose) as a factor a significant effect of the 
exposure was shown in female FT4 levels [F(1,24)=6.237, p=0.02]. 
Females exposed to BDE-209 showed a decrease in FT4 hormone levels 
(Figure II.22). The same analyses were carried out by group (genotype and 
sex), but no significant differences among treatment conditions were found 
in any group.  
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Figure II.21. Levels of thyroid hormones by genotype 
 
 Data are expressed as mean and S.E.M. Groups showing different letters a,b,c are 
different from each other at p < 0.05. 
Figure II.22. Levels of free T4; Effects of sex and treatment 
 
Data are expressed as mean and S.E.M. Groups showing different 
letters a,b  are different from each other at p < 0.05. 
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BDNF and TrkB receptor levels 
 
A two-way ANOVA (genotype x treatment) was performed on the levels of 
BDNF and TrkB in the hippocampus. Results showed an overall effect of 
the genotype on both the BDNF levels [F(2,37)=3.845, p=0.032] and the 
TrkB receptor levels [F(2,37)=23.613, p<0.001] (Figure II.24). No effects 





Figure II.23. BDNF and TrkB levels in the hippocampus 
 
Data are expressed as mean and S.E.M. for control and exposed ApoE2, ApoE3 
and ApoE4 male mice. Groups showing different letters a,b,c are different from 
each other at p<0.05. 
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2.2 Discussion of Experimental Phase II: 4 months old 
 
ApoE genotype showed a strong influence on behaviour and interacted 
with sex and with neonatal exposure to BDE-209 effects in young adults.  
 
In this study, differences in body weight between ApoE genotypes at 4 
months of age were only observed in female mice. ApoE4 females showed 
lower body weight compared to both ApoE2 and ApoE3 females. 
Accordingly, the French group of Mathis and co-workers found lower body 
weight in ApoE4 mice compared to ApoE3 at 4 months of age, especially 
in females (Grootendorst et al. 2005). Human studies also support the role 
of ApoE in the regulation of the metabolism and associate the ApoE4 allele 
with lower body weight (Long et al. 2003; Arbones-Mainar et al. 2008; 
Pendse et al. 2009; Ferreira et al. 2011). Exploratory behaviour, locomotor 
activity and anxiety were also affected by the ApoE genotype in mice. 
ApoE4 mice showed less exploration activity in the EZM and in the OF 
compared to ApoE2 and ApoE3 mice. In agreement with this result, 
Grottendorst and collaborators found less activity in ApoE4 mice compared 
to ApoE3 at 4-5 months of age, and Siegel and coworkers found that at 6-8 
months of age ApoE4 female mice moved less in the Open Field than 
ApoE2 and ApoE3 (Grootendorst et al. 2005; Siegel et al. 2010). On the 
contrary, ApoE4-GFAP mice did not differ in activity levels from ApoE3-
GFAP mice (Hartman et al. 2001). Surprisingly, our results revealed that 
ApoE2 travelled longer distances in Open Field compared to ApoE3 and 
ApoE4; this increased activity was observed especially in ApoE2 females, 
which maintained high levels of activity during the whole testing period. 
ApoE2 hyperactivity has not been reported before and differs from a recent 
study where ApoE2 females aged 6-8 months moved like ApoE3 females 
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(Siegel et al. 2010). As we have not found higher activity in ApoE2 in the 
EZM, which is a more anxiogenic test, we speculated that differences in the 
protocol might be the reason for these discrepancies. That is to say that the 
anxiety component might mask differences in the levels of activity. These 
effects should be further investigated. Interestingly, in our study differences 
found in activity are not likely to be beyond differences in body weight, 
which are probably more related to metabolic rate characteristics in these 
genotypes. 
 
Anxiety-like behaviour was also affected by the genotype. In the EZM, 
ApoE4 mice made fewer crossings into the open area, spent less time there, 
and showed more freezing compared to ApoE2 and ApoE3. In the OF, 
ApoE4 also made fewer entries into the centre compared to the other 
genotypes and spent less time in the centre compared to ApoE3. Broadly, 
ApoE3 exhibited the less anxious phenotype among the three genotypes, 
while ApoE4 showed the most anxious one. Differential effects on 
measures of anxiety related to ApoE isoforms have been reported 
previously, likewise indicating high anxiety scores in ApoE4 mice 
(Robertson et al. 2005; Raber 2007; Siegel et al. 2010).  
 
The three ApoE genotypes also showed differences in spatial learning in 
the MWM spatial reference task. ApoE4 took longer to reach the hidden 
platform throughout the training, while ApoE3 achieved very good 
latencies from the fourth session onwards. ApoE3 also reached the platform 
in the shortest distance and had better retention ability compared to the 
other genotypes. Other studies that have investigated spatial learning 
related to ApoE isoforms did not find any differences in acquisition at 
young ages, but impaired retention in ApoE4, especially in females (Raber 
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et al. 2000; Grootendorst et al. 2005; van Meer et al. 2007). On the other 
hand, Siegel et al (2010) obtained a better performance in the MWM 
acquisition in young ApoE4 females, and no genotype differences in 
retention (Siegel et al. 2010). These differences between studies might be 
due to differences in the spatial task protocol. . In this study, we added a 
rotational inner wall to the apparatus in order to avoid intra-maze cues, 
which has been shown to be more sensitive to detect spatial learning 
impairments in a transgenic animal model for Alzheimer’s disease (Ribes 
et al. 2008). This modification prevents the animals from using a strategy 
based in proximal cues, and might account for the differences in spatial 
learning performance observed among the genotypes. Fewer trials per day 
and a long training period in our experiment, might explain why all the 
groups achieve good learning results at the end of the training and 
comparable retention performance among genotypes.   
 
Thyroid hormone levels in mice were also influenced by the ApoE 
genotype. In our study, ApoE2 mice showed lower levels of thyroid 
hormones in blood serum compared with ApoE3 and ApoE4, although a 
significant difference was observed only for T3 levels. This suggests there 
might be a reduction in hormone synthesis in the ApoE2 group. There is 
evidence in the literature of an interaction between thyroid hormones and 
apolipoproteins, although studies relating ApoE polimorphisms with 
thyroid hormone levels are rare. Lipoproteins, especially  HDL, are plasma 
carriers for a small number of thyroid hormones, which bind by 
interactions with the specific apolipoproteins including ApoE (Benvenga 
1997; Benvenga et al. 1999). Furthermore, the expression of the ApoE gene 
can be controlled by thyroid hormones (Vandenbrouck et al. 1994). Among 
children with hypothyroidism, no differences have been reported linked to 
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ApoE genotypes (Ciomartan et al. 1999). Instead, a recent study found low 
levels of FT4 in postmenopausal women carrying ApoE2 or ApoE4 alleles 
compared with the E3/3 genotype. On the other hand, ApoE2 carriers 
showed higher levels of anti-TG antibodies (Lambrinoudaki et al. 2009). 
Taken together, the data suggest that the ApoE genotype is related to 
differences in thyroid hormone levels, which modulate brain organization 
and function and consequently may influence behaviour. More studies are 
needed to assess thyroid hormones among ApoE genotypes in humans. 
 
Finally, we found differences in BDNF levels in the hippocampus, among 
ApoE2 mice compared to ApoE4 mice, while levels of ApoE3 were similar 
to the other two genotypes. We also observed differences between 
genotypes in levels of the BDNF receptor TrkB. ApoE2 showed the highest 
receptor levels, while ApoE3 showed the lowest. Nichol and co-workers 
reported similar levels of BDNF in the hippocampus of ApoE3 and ApoE4 
mice, but they did not report data on ApoE2 mice. They also observed 
lower TrkB receptor levels in sedentary ApoE4 mice compared to ApoE3, 
but these levels increased with exercise in ApoE4 mice (Nichol et al. 
2009). There are some differences related to the age and housing of the 
mice between that study and our study. In Nichol’s study mice were 10-12 
months and housed alone, while in our study, mice were 6 months old and 
housed in a group, and we did not introduce any exercise conditions. 
BDNF is involved in synaptic plasticity, neuronal differentiation and 
survival of neurons (Klein et al. 2011), so any challenge inducing activity 
in the CNS might modify these levels.  
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It should be highlighted that in our study, neonatal BDE-209 exposure has 
been shown to affect body weight, behaviour and learning in young adults, 
depending on the genotype and sex.  
 
ApoE4 males exposed to low and high doses of BDE-209 showed a 
significant decrease in body weight compared to ApoE4 control males. 
Instead, ApoE3 exposed females showed a slight increase in body weight. 
Few studies report changes in body weight after perinatal PBDE exposure 
in young adult rodents (Eriksson et al. 2002; Viberg et al. 2002; Viberg et 
al. 2003; Viberg et al. 2003; Viberg et al. 2004; Viberg et al. 2007; 
Johansson et al. 2008), or after post-weaning administering or chronic 
exposure of PBDE (Stoker et al. 2004; Darnerud et al. 2007; Richardson et 
al. 2008; Driscoll et al. 2009). Only two investigations report a higher body 
weight in animals postnatally exposed to low-brominated compounds, 
which appeared after the developing period at 1 or 2 months of age 
(Dufault et al. 2005; Gee et al. 2008).  
Postnatal exposure to BDE-209 showed to affect activity levels at 4 
months, depending on the genotype and sex. Rearing increased in treated 
ApoE2 male mice, while it decreased in ApoE3 and ApoE4 females. 
ApoE4 females were more affected by the treatment since they showed 
diminished rearing, decreased distance travelled and fewer crossings to the 
centre. Effects of PBDEs in locomotor activity have been widely reported 
in rodents, usually characterized by hyperactivity and lack of habituation 
(Eriksson et al. 2002; Viberg et al. 2002; Viberg et al. 2003; Viberg et al. 
2004; Branchi et al. 2005; Kuriyama et al. 2007; Gee et al. 2008). The 
BDE-209 compound has also been shown to disrupt locomotor activity in 
adulthood, after an early postnatal exposure. Regarding this, the Swedish 
group of Eriksson and coworkers observed initial hypoactivity followed by 
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hyperactivity due to the lack of habituation in rats and mice (2,4 and 6 
months old) exposed to a single oral dose of BDE-209 on PND3 (Viberg et 
al. 2003; Viberg et al. 2007; Johansson et al. 2008). Rice and collaborators 
observed an effect of hyperactivity in 2-months-old C57BL/6J male mice 
exposed to BDE-209 from PND2 to PND15. In our experiment BDE-209 
affected the pattern of habituation, inducing hyperactivity in ApoE2 males, 
while ApoE4 exposed females showed hypoactivity.  
 
In our study, spatial learning and memory at 4 months was affected by 
BDE-209 treatment only in ApoE3 males. ApoE3 males exposed to high 
doses showed higher latencies and distance travelled to reach the hidden 
platform during acquisition and showed worse retention in the second 
probe trial compared to their control counterparts. Learning and memory 
have been also studied after neonatal exposure to PBDEs. Impaired 
learning in a visual discrimination task was observed in adult rats after 
postnatal exposure to penta DE-71. Exposed rats, compared to controls, 
committed more errors and omissions and required more trials to reach the 
criterion in the five choice serial reaction task (Dufault et al. 2005). 
Referring to spatial learning, tetra BDE-47 exposure impaired both 
acquisition and retention in a MWM (He et al. 2009), while animals 
exposed to penta, hexa and octa congeners had higher latencies during 
acquisition and impaired re-learning processes (Eriksson et al. 2001; 
Viberg et al. 2003; Viberg et al. 2006; Cheng et al. 2009). The effect of the 
BDE-209 exposure in the MWM performance has not previously been 
assessed, but impaired performance in a light-dark discrimination task was 
observed in old mice (16 months) although not in the young, after postnatal 
exposure to BDE-209 (Rice et al. 2009). In the current study, we have seen 
that the ApoE3 mice, which were the best learner, showed poorer 
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acquisition performance and retention in the MWM, four months after 
acute exposure to BDE-209 at PND10. 
 
Collecting all behavioural data, we can determine that BDE-209 affects 
specific functional domains depending on the genotype. The weak point of 
ApoE4, which was their lower activity levels, was disrupted by BDE-209, 
causing more hypoactivity in females. Instead, BDE-209 affected the 
strong point in ApoE3 male mice, impairing their good learning and 
memory. For the latter, we suspect that effects in other genotypes are 
masked by the strong genotype influence.   
 
Levels of thyroid hormone were also affected by BDE-209 exposure in 
female mice. Females exposed postnatally to BDE-209 showed significant 
lower levels of FT4 compared to control females at four months. The 
effects of PBDE as endocrine disruptors are well known, and their effects 
on thyroid hormones are widely reported. Total serum and free T4 have 
been found to decreases in humans and rodents after exposure to lower 
bromine compounds during both the gestational period and after birth 
(Zhou et al. 2002; Branchi et al. 2005; Darnerud et al. 2007; Kuriyama et 
al. 2007; Rice et al. 2007; Richardson et al. 2008). The effects of BDE-209 
on thyroid hormones have recently been studied. Lower T4 and T3 was 
found in dams (Chi et al. 2011) and in female rat offspring (Kim et al. 
2009) exposed to very high doses of BDE-209 during gestation. As far as 
we know, this is the first study to report changes in thyroid hormone levels 
after acute postnatal exposure to BDE-209 at relevant doses for human 
exposure. Because the only hormone affected is FT4, the reduction of FT4 
levels in exposed females might be related to an increase in its degradation 
by UDGPT, which was reported by Zhou et al (2002).  
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 On the whole, results of the second experimental phase indicate that early 
postnatal exposure to BDE-209 produces long-term derangements in 
different aspects of the behavioural spectrum and hormonal alterations, 
depending on distinct genetic vulnerabilities and sex. 
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3. Experimental Phase III: 12 months-old 
 
Experimental Phase III consisted in the evaluation of ApoE transgenic 
female mice at 12 months of age that had been exposed to BDE-209 on 
PND10. Anxiety and locomotor activity were assessed in an EZM and an 
OF. Spatial learning and memory were assessed in a MWM spatial 
reference task. The results of the third experimental phase are explained in 
the following pages, organized as follows: body weight, anxiety and 
activity measures in the Elevated Zero Maze and in the Open Field, and 
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Body weight of ApoE female mice at 12 months of age was analysed by a 
two-way ANOVA (genotype x treatment) and an overall effect of the 
genotype was observed [F(2,89)=4.957, p=0.009] (Figure III.1).  
Analysing the effect of the treatment in each genotype separately, an effect 
of BDE-209 exposure emerged in the ApoE4 group when control group 
was compared to the low and the high doses taken together [F(1,36)=4.504, 





Figure III.1. Body weight at 12 months of age by genotype 
 
Data is expressed as mean and S.E.M. Groups showing different 
letters a,b are significantly different from each other at p < 0.05.  
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Elevated Zero Maze 
 
The evaluation of anxiety at twelve months of age was conducted in an 
EZM test. Nine animals were excluded from the analyses because they fell 
off the apparatus (Table 5).  
 









0 mg/kg 1 2 4 7 
10 mg/kg 0 0 0 0 
30 mg/kg - 0 1 1 
 1 2 5  
Table 5. Number of animals excluded from the statistical analyses because they fell  
off the EZM, and its distribution among groups. Data are expressed as absolute values.  
Figure III.2. Body weight at 12 months of age by genotype and treatment 
 
Data is expressed as mean and S.E.M. Groups showing an asterisk differ at p < 0.05.  
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The analysis of the behaviour in the EZM was carried out by a two-way 
ANOVA (genotype x treatment) on the latency to enter the closed area, the 
time spent in the open area, the number of crossings from the closed to the 
open area, and the number of head dips, rearing, grooming, freezing and 
defecation. A correction was made to the time spent in the open area; we 
subtracted the latency to enter the closed area from the total time spent in 
the open area.  This correction was made in order to find a measure of the 
time the animals spent in the open area when they crossed voluntarily. The 
number of crossings from the closed to the open area and the corrected time 
in the open area did not show variance homogeneity, so the non-
parametrical Kruskall-Wallis test was used to analyse these variables. 
 
An overall effect of the genotype was found in the corrected time in the 
open area [X
2
=19.945, p<0.001], in the number of crossings [X
2
=25.484, 
p<0.001], in the number of head-dips [F(2,80)=4.744, p=0.012], in rearing 
[F(2,80)=4.463, p=0.015] and in freezing [F(2,80)=3.884, p=0.025]. ApoE4 
made fewer crossings and spent less time in the open area and also carried 
out less rearing and more freezing than the other genotypes. ApoE2 did 
more head-dips compared to the other genotypes (Figure III.3). No effects 
of the BDE-209 treatment were observed.  
 
A one-way ANOVA was performed in each genotype separately, but no 
differential effects of the BDE-209 treatment were observed in any of the 
genotypes (Figure III.4). 
 
In summary, the results of the EZM showed increased levels of anxiety and 
decreased exploration in ApoE4 females at 12 months of age. BDE-209 
treatment does not affect behaviour in the EZM at 12 months of age. 
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Figure III.3. Behaviour in an EZM at 12 months of age by genotype 
 
Data are expressed as mean and S.E.M. Groups showing different letters a,b,c are 
different from each other at p < 0.05.  
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Figure III.4. Behaviour in the EZM at 12 months old by genotype 
and treatment  
 
Data is expressed as mean and S.E.M. 
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Open Field 
 
The evaluation of anxiety and locomotor activity at 12 months old was also 
carried out in an OF test. General activity was analysed by two-way 
ANOVA (genotype x treatment) for repeated measures using six 5-min 
periods as a within-subject factor and the distance travelled (cm) as a 
dependent variable. There was a significant effect of the period of time on 
the distance travelled [F(5, 89) = 25.902, p<0.001], indicating that the 
animals habituate to the new space. An overall effect of genotype [F(2,89)= 
10.395, p<0.001] was found in the distance travelled throughout the test 





Figure III.5. Distance travelled in the OF by genotype at 12 months  
 
Data is expressed as mean and S.E.M. The asterisk indicates ApoE2 differ from the 
other genotypes, and the symbol # that all genotypes differ among them, at p < 0.05.  
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A two-way ANOVA (genotype x treatment) was performed on the total 
distance travelled and the total rearing performed. These variables did not 
show variance homogeneity, so the non-parametrical Kruskall-Wallis test 
was used. An overall effect of the genotype was found in the total number 
of rearings [F(2,89)=12.495, p<0.001] and the total distance travelled (cm) 
[F(2,89)=10.395, p<0.001], showing lower levels of activity in ApoE4 
females (Figure III.6). No effects of the BDE-209 treatment were observed 






Since all the genotypes showed different activity levels in the OF, a more 
detailed analysis was performed in each genotype. A one-way ANOVA for 
repeated measures was carried out, using six 5-min periods as a within-
subject factor and the distance travelled as a dependent variable. Results 
Figure III.6. General activity in the OF by genotype at 12 months of age 
 
Total distance traveled (A) and total rearing (B). Data are expressed as mean and 
S.E.M. Groups showing different letters a,b are different from each other at p < 0.05.  
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showed an effect of time on distance travelled in all the genotypes; ApoE2 
[F(5, 16) = 5.830, p=0.011], ApoE3 [F(5, 36) = 44.303, p<0.001] and 
ApoE4 [F(5, 36) = 25.358, p<0.001] (Figure III.7), indicating that there 
were no genotype differences in habituation, as we have seen above. No 






To evaluate anxiety behaviour in the OF, a two-way ANOVA (genotype x 
treatment) was performed on the number of entries to the centre, the time 
spent in the centre, the ratio of rearing in the centre (rearing in the centre / 
total rearing) and the ratio of distance travelled in the centre (distance in the 
centre/total distance). The non-parametrical Kruskall-Wallis test was used 
for the distance travelled in the centre. An overall effect of the genotype 
was significant in the entries to the centre [F(2,89)=10.072, p<0.001], the 
Figure III.7. Distance travelled in the OF by genotype and treatment 
 
Data is expressed as mean and S.E.M.  
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time spent in the centre [F(2,89)=5.240, p=0.007], the ratio of rearing in the 
centre [F(2,89)=4.359, p=0.016] and the ratio of distance travelled in the 
centre [F(2,89)=10.242, p<0.001] (Figure III.8). No effects of the BDE-209 
treatment were observed.  
 
 
Figure III.8. Activity in the centre of the OF by genotype  
 
Number of entries (A) and time spent into the centre (B) Ratio of distance travelled 
(C) and ratio of rearing (D) in the centre. Data are expressed as mean and S.E.M. 
Groups showing different letters a,b are different from each other at p < 0.05.  
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An analysis of the activity in the centre was also carried out in each 
genotype separately. Taking together the low and the high dose groups, an 
effect of the BDE-209 exposure was observed in ApoE3 on the ratio of the 
distance travelled in the centre [F(2,36)=7.023, p=0.012] and on the ratio of 
rearing in the centre [F(2,36)=4.929, p=0.033] (Figure III.9). 
 
 
Figure III.9. Activity in the center of OF by genotype and treatment 
 
Data are expressed as mean and S.E.M.  
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In summary, OF results show that ApoE4 displays lower activity levels. 
The ApoE3 mice showed less anxiety-like behaviour, but BDE-209 
exposure might increase their anxiety levels, equating them with the other 
genotypes. 
 
Morris Water Maze reference memory task 
 
Spatial learning in the MWM at 12 months of age was analysed by a two-
way ANOVA (genotype x treatment) for repeated measures on the latency 
(s) to get to the hidden platform, the distance travelled (cm), and the search 
velocity (cm/s) through the ten sessions of acquisition.  
 
There was an effect of the session on the latency [F (9,89)= 80.393, 
p<0.001], on the distance travelled [F (9,89)= 72.726, p<0.001] and on the 
search velocity [F (9,89)= 9.292, p<0.001], indicating that the mice 
improved over the sessions during the acquisition period. 
 
An overall effect of the genotype was found in the latency [F (2,89)= 
7.704, p<0.001], the distance travelled [F (2,89)= 6.184, p=0.004] and the 
search velocity [F (2,89)= 11.480, p<0.001]. ApoE4 group differed from 
the ApoE3 in the total latency and from the other two genotypes in the 
distance travelled to get to the platform during the acquisition, while 
ApoE2 differed from the other two genotypes in the search velocity (Figure 
III.10). A significant effect of the treatment was also found in the distance 
travelled (cm) to the platform [F (2,89)= 5.253, p=0.008], in that the 
females exposed to a high dose differed from the control (Figure III.11).  
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Figure III.10. MWM acquisition by genotype at 12 months of age 
 
Escape latency, distance travelled and search velocity (A, B, C) and their mean of ten 
sessions (D, E, F). Data are expressed as mean and S.E.M. The symbols express 
differences at p < 0.05 between: ApoE4 and the other genotypes (#), ApoE4 and 
ApoE3 (*), ApoE4 and ApoE2 ($), ApoE2 and the other grenotypes (&), all the 
genotypes differ among them (+).   
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Figure III.11. MWM acquisition by genotype at 12 months of age 
 
Escape latency, distance travelled and search velocity (A, B, C) and their mean of ten 
sessions (D, E, F). Data are expressed as mean and S.E.M. The asterisk indicates 
differences (p < 0.05) between the control and the exposed mice at both the low and 
high dose.   
UNIVERSITAT ROVIRA I VIRGILI 
NEUROBEHAVIOURAL EFFECTS ASSOCIATED WITH POSTNATAL EXPOSURE TO DECABROMODIPHENYL ETHER IN APOE2, 
APOE3 AND APOE4 TRANSGENIC MICE 
Ingrid Reverté Soler 
DL:T. 162-2012 
     Results of the Experimental Phase III: 12 months old 
           -  - 187 
We also analysed separately the effect of BDE-209 exposure on the 
acquisition performance in each genotype. A significant effect of the 
session was observed in the escape latency for each genotype (p<0.01), 
likewise observed in the general analysis. In the ApoE4 group an 
interaction between the session, distance and treatment was also observed 
[F (9,36)= 1.916, p=0.048]. 
  
In ApoE2 females, an overall effect of the treatment was found in escape 
latency [F (2,15)= 7.917, p=0.015], as well as a trend towards a treatment 
effect in distance travelled [F (2,15)= 4.739, p=0.057]. Those effects 
indicate differences in the acquisition of the task between the control 
ApoE2 females and the exposed to a low dose. A trend towards a treatment 
effect in distance travelled was also found in ApoE3 female mice [F 
(2,36)= 3.099, p=0.066], pointing to differences between control and high 
dose exposed mice (Figure III.12).  
 
In summary, results of the MWM acquisition showed that at 12 months 
ApoE4 females performed worse in a spatial task compared to the other 
genotypes. The treatment increases the escape latency in all the genotypes, 
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Figure III.12. MWM acquisition by genotype and treatment at 12 
months  
 
Escape latency and distance travelled through the 10 days of acquisition. Data are 
expressed as mean and S.E.M. The symbols indicate differences between: the control 
and low dose groups (+), the control and the high dose groups (#) and the the low 
dose and both the control and high dose groups ($). p < 0.05.   
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Retention of the MWM 
 
We analysed the retention ability in the four probe trials performed during 
the acquisition period. A two-way ANOVA (genotype x treatment) for 
repeated measures was performed, using the session at the probe trial as a 
within-subject factor and the time spent (s) in the target quadrant (Tgq) and 
the distance travelled (cm) in the Tgq as dependent variables. 
 
An effect of the session was significant on both the time spent in the Tgq 
[F(3,89 )=9.225,p<0.001] and the distance travelled in the Tgq 
[F(3,89)=6.705,p<0.001] indicating an improvement through sessions. An 
overall effect of the genotype was observed in the distance travelled in the 
Tgq [F(2,89)=4.888,p=0.010], showing differences between ApoE3 and 
ApoE4 mice (Figure III.13). There was no observed effect of the treatment 
in the whole group. 
 
Retention ability was additionally analysed in each genotype. A change 
was observed through the sessions on the time and the distance travelled in 
the Tgq in all the genotypes (p<0.001), as previously observed. An effect of 
the treatment was found between the control and the high dose exposed 
ApoE3 mice in the fifth session (Figures III.14 and III.15). ApoE3 mice 
exposed to the high dose showed worse retention in the fifth session 
compared to their control counterparts.  
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Figure III.13. Retention in the MWM by genotype at 12 
months of age 
 
Time spent (A) and distance travelled (B) in the Tgq. Data are expressed 
as mean and S.E.M. The asterisk indicates differences between groups at 
p< 0.05. The dashed line indicates execution by chance.  
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Figure III.14. Retention in the MWM by genotype and 
treatment at 12 months of age 
 
Time spent in the Tgq. Data are expressed as mean and S.E.M. The asterisk 
indicates differences between groups at p< 0.05. 
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Figure III.15. Retention in the MWM by genotype and 
treatment at 12 months of age 
 
Distance travelled in the Tgq. Data are expressed as mean and S.E.M.  
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Long-term retention 
 
The time (s) spent in the target quadrant (Tgq) and the distance travelled 
(cm) in the Tgq during the 72h probe trial were both analysed as long-term 
retention variables. A two-way ANOVA (genotype x treatment) was 
performed.  
 
Results showed an overall effect of the genotype in the time spent in the 
Tgq [F(2,89)=3.328, p=0.041], but there were no significant, observable 
differences between groups.  Likewise, a one-way ANOVA performed by 
genotype, using the treatment as a between-subject factor, only points to a 
possible trend effect of the treatment in the time spent in the Tgq in ApoE3 
group [F(2,36)=2.826,p=0.073]. Additionally, we compared control 
animals with exposed animals (taking both the low and the high dose 
groups) and an effect of treatment emerged in ApoE3 
[F(1,36)=5.448,p=0.025] (Figure III.16). The interpretation of these results 
should be made taking into account the low scores reached in the long-term 
retention by ApoE3 females exposed to BDE-209, which obtained scores 
similar to the chance level. 
 
Briefly, the results on the retention of the MWM reveal old ApoE2 females 
performed above the chance level during the acquisition, although they 
never reached the recall levels that the ApoE4 and ApoE3 reached. ApoE4 
females need more training trials to show a recall comparable to ApoE3. 
ApoE3 females were affected by the treatment, since those exposed to the 
high dose showed a poor performance in the second probe trial and in long 
retention sessions compared to control ApoE3 females. 
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Figure III.16. Long-term retention in the MWM by genotype 
and treatment at 12 months of age  
 
Time spent (A) and distance travelled (B) in the Tgq. Data are expressed 
as mean and S.E.M. The dashed line indicates execution by chance.  
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3.2 Discussion of the Experimental Phase III: 12 months old 
 
ApoE female mice showed behavioural differences among genotypes and 
differential effects to postnatal exposure to BDE-209 at 12 months of age.  
 
In this study, differences in body weight in old females were found 
regarding the ApoE genotype. ApoE4 female mice had a lower body 
weight compared with ApoE3 females. It is well known that ApoE 
influences metabolism and body weight, and human ApoE isoforms are 
associated with increasing body mass index in the order: 
ApoE2>ApoE3>ApoE4 (Arbones-Mainar et al. 2008; Pendse et al. 2009; 
Ferreira et al. 2011). Supporting this relationship, a recent study found 
higher body mass index in menopausal Korean woman homozygote for the 
ApoE3 allele (Lee et al. 2011). On the other hand, Bour and colleagues 
found increased body weight in male and female ApoE4 mice at 15 months 
old (Bour et al. 2008). Discrepancies between these studies could be related 
to age or stressful conditions during the testing procedure, such as the 
individual housing in Bour’s study.  
 
Results in the Zero Maze and the Open Field tests showed that ApoE4 is 
clearly hypoactive compared to the other genotypes. Decreased locomotor 
activity was previously reported in ApoE4 males at 15 months old (Bour et 
al. 2008), and in ApoE4 females from 10 to 22 months old (Siegel et al. 
2010). Referring to the habituation to a new environment, all the animals in 
our study decreased their activity over time, independently of the genotype, 
but ApoE2 females showed higher levels of activity throughout the test. 
ApoE4 females showed more freezing and explored for less time the open 
areas of the EZM, indicating higher levels of anxiety compared to ApoE2 
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and ApoE3 mice. In the OF, ApoE4 female mice also made fewer entries to 
the centre of the maze compared to the other genotypes, supporting anxiety 
data obtained from the EZM. The ApoE3 mice explored for more time and 
were more active in the centre of the Open Field compared to the other 
genotypes, showing the least anxious phenotype at 12 months old. 
Increased measures of anxiety in ApoE4 mice were previously reported, 
and differences among ApoE genotypes become more evident with age 
(Raber 2007; Siegel et al. 2010). Studies in humans also support the 
association of the ApoE4 genotype with high anxiety levels. ApoE4 
homozygous allele carriers showed higher anxiety scores compared with 
the homozygous for the ApoE3 allele, in subjects with probable AD 
(Robertson et al. 2005), and increased stress markers were found in carriers 
of the ApoE4 and a variant of the butyrylcholinesterase gene (Fiocco et al. 
2009).  
 
Spatial navigation and learning was influenced by the genotype at 12 
months of age in the current study. ApoE4 spent more time and travelled 
more distances to reach the platform in comparison with ApoE2 and 
ApoE3 females. However, all the groups achieved good learning scores at 
the end of the acquisition period. Accordingly, Bour and colleagues found a 
lower global performance in the MWM in ApoE4 female mice (Bour et al. 
2008) On the contrary,  improved spatial learning in ApoE4 mice was 
found in 10-13 and 14-22 months-old females (Siegel et al. 2010). These 
discrepancies among studies might be due to differences in the protocol 
used in the MWM spatial reference task. In the current study, ApoE4 
females at 12 months also showed worse retention ability in the second 
probe trial compared with ApoE3 females, although they improved their 
retention with training. Instead, retention ability in ApoE2 females was 
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poor during the whole training period, though they performed over the 
chance level. The Mathis group observed in ApoE4 females no preference 
for the target quadrant in a probe trial performed 24 hours after the last 
training session (Bour et al. 2008). In contrast, Siegel and colleagues did 
not find any differences among genotypes in retention of the MWM task at 
10-13 or 14-22 months of age (Siegel et al. 2010). A possible explanation is 
that in Siegel’s study probe trials were carried out one hour after the 
training session, and the ApoE4 genotype possibly preserves short-term 
memory. Instead, when probe trials take place 24 hours after the training 
session, detrimental memory effects appear. There were no differences in 
long-term retention (72h probe trial) among genotypes at 12 months of age 
in the present study, indicating that long-term retention is not affected. The 
poor retention exhibited by ApoE2 females is unexpected since their 
acquisition is as good as that observed in ApoE3 females. A workable 
explanation might be that the high swim velocity shown by this genotype 
causes longer trajectories not restrained to the target quadrant. Another 
possibility could be related to higher cognitive flexibility in ApoE2, which 
makes these animals search for the platform across all the quadrants when 
they do not find it in the last position. Nonetheless, these are just 
considerations and ApoE2 memory capacity should be studied further. 
 
Exposure to BDE-209 during the postnatal period was shown to affect 
behaviour and learning of female mice at 12 months of age, depending on 
the genotype.  
 
Body weight was lower in ApoE4 females exposed to BDE-209. Generally, 
studies do not report changes in body weight after PBDE exposure 
(Eriksson et al. 2002; Viberg et al. 2002; Viberg et al. 2003; Viberg et al. 
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2003; Viberg et al. 2004; Viberg et al. 2007; Johansson et al. 2008), so it is 
plausible the BDE-209 interacts with the metabolic susceptibility of the 
ApoE4 genotype.   
 
BDE-209 exposure did not affect behaviour in the EZM or general activity 
in the OF test at 12 months of age, but triggered a decrease in the 
exploration activity in the centre of the maze in ApoE3 female mice. 
ApoE3 female mice showed high exploratory activity in the centre of the 
OF, indicating low levels of anxiety, which were increased in treated 
animals. No differences in the time spent in open arms in an EPM were 
found in NMRI mice at 2 or 4 months of age, after being exposed to BDE-
209 on PND3 (Johansson et al. 2008). In the other hand, CD-1 Swiss 
female mice spent more time in the centre of the OF 2 months after 
postnatal exposure to BDE-99 (Branchi et al. 2002). The differences 
between strain, age and testing approach may be explanations for these 
differences. 
 
Learning and memory were also affected by BDE-209 exposure since both 
acquisition and retention in the MWM task were impaired by the treatment. 
At 12 months of age, the escape latency and the distance travelled to reach 
the platform were higher during the first days of training, in the animals 
exposed at PND10 to the low and high dose of BDE-209. Those 
impairments during the acquisition period were more evident in ApoE2 and 
ApoE3 female mice. ApoE3 female mice exposed to BDE-209 also 
required more training trials to show good retention scores in comparison 
with ApoE3 control females. Furthermore, long-term retention was reduced 
in BDE-209 exposed ApoE3 females. Learning and memory derangements 
in rodents after PBDE exposure have been shown in spatial tasks (Eriksson 
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et al. 2001; Viberg et al. 2003; Viberg et al. 2006; Cheng et al. 2009; He et 
al. 2009) as well in non-spatial tasks (Dufault et al. 2005). Spatial learning 
and memory in the MWM after administration of BDE-209 have not been 
studied previously, but neonatal exposure to BDE-209 impaired learning in 
a light-dark discrimination task in 16-months-old mice (Rice et al. 2009). 
Rice and co-workers were the first to report such long-term effects after 
neonatal exposure to PBDEs. Regarding that, our study provides additional 
evidence of long lasting effects of neonatal exposure to BDE-209, which is 
able to disrupt behaviour, learning and memory twelve months after 
exposure, and interact with the genotype suppressing the cognitive 
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Chapter V: General Discussion 
and Future Perspectives 
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In the present study the effects of an acute postnatal exposure to 
BDE-209 were evaluated at three major moments of life: the 
developmental period, young adulthood and old age, in ApoE2, ApoE3 and 
ApoE4 mice. Some of the effects observed are transient, while others are 
present in all the experimental phases. In this chapter, the results are 
discussed as a whole, offering a lifecycle perspective on the 
neurobehavioural performance of ApoE mice and the short and long term 
effects of the postnatal exposure to BDE-209 in this animal model. 
 
Physical and behavioural differences among genotypes were observed in all 
the experimental phases, providing support for the idea that the ApoE 
genotype is not only a risk factor for disease in the elderly, but it provides 
different cognitive and behavioural phenotypes from birth. During 
development, ApoE4 mice showed a delay in the acquisition of some 
neuromotor abilities compared to the other genotypes, which was no longer 
observed in adults. Additionally, our study clearly points to a diminished 
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reproductive outcome in ApoE4 genotype as well as a delayed maturation 
in male mice. Human ApoE is the most important supplier of the 
cholesterol precursor for steroid production and could play an important 
role in the regulation of steroid hormone function, sexual maturation or 
reproduction (Corbo et al. 2004). However, there have been few studies on 
this topic, and there are only a few references on the relationship between 
ApoE polymorphisms and fertility.  
 
Furthermore, mice showing different ApoE isoforms were differentially 
affected by the exposure to BDE-209, showing that ApoE2 mice are more 
vulnerable to toxic effects during development. ApoE2 mice exposed to 
BDE-209, especially those exposed to the high dose, showed a delay in 
physical and neuromotor development. Sexual maturation was delayed in 
BDE-209 exposed males independently of the genotype, and in ApoE2 
females exposed to BDE-209. Previously, lower brominated congeners 
have been proven to delay puberty in exposed male and female rodents 
(Stoker et al. 2005; Lilienthal et al. 2006) and this effect could be mediated 
by the ability of PBDEs to interact with sexual hormones (Costa et al. 
2007; Talsness 2008). In this study, sexual or reproductive features were 
not examined in adult ApoE mice, so we do not know if the effects 
observed in exposed males and ApoE2 females remain in adults and/or turn 
into an impaired reproductive capacity. The effects of PBDEs in adult 
reproductive organs are reported after exposure to low doses of tetra and 
penta-BDEs, but BDE-209 does not generally effect reproduction in adults 
((EFSA) 2011). The myelin pattern was also affected by BDE-209 
treatment in ApoE2, which could account for developmental retardation 
observed in exposed animals of this genotype. The myelination process is 
essential for a proper CNS function and is suitable to be disrupted by 
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environmental conditions such as nutritional deficits or toxic exposure 
during critical stages (Di Biase et al. 1997; Georgieff 2007; Pott et al. 
2009). The mechanisms by which BDE-209 alters myelin compaction in 
ApoE2 genotype might be diverse; one of them could be mediated by 
thyroid hormones. Thyroid hormone deficiency alters myelin sheath 
compaction (Ferreira et al. 2007), and there is a lot of evidence of thyroid 
hormone disruption after PBDE exposure (Zhou et al. 2002; Branchi et al. 
2003; Stoker et al. 2004; Ellis-Hutchings et al. 2006; Darnerud et al. 2007; 
Kuriyama et al. 2007; Richardson et al. 2008; Driscoll et al. 2009). In this 
study, the status of the thyroid hormone assessed at four months of age 
revealed an effect of BDE-209 exposure over FT4 levels in females. In 
addition, T3 was lower in the ApoE2 genotype, independently of the 
treatment. The inherent low T3 levels in ApoE2 may be worsened by BDE-
209 exposure, which may then lead to a delayed myelin compaction 
pattern. Since BDE-209 does not modify thyroid levels in adult males, a 
more detailed study is needed of the thyroidal status during development 
after acute exposure to BDE-209 in order to better characterize the 
relationship between thyroid status in male ApoE2 mice and myelination. 
Another explanation for the myelination differences observed between the 
control and the BDE-209 exposed ApoE2 males is the difference in 
cholesterol metabolism in brain among genotypes (Dietschy 2009). ApoE2 
mice were the most affected by the treatment during development and this 
might be related to the high cholesterol demands due to the rapid growth 
during this period. The absorption of cholesterol by the intestine is lower in 
ApoE2 phenotypes compared to ApoE4 (Scacchi et al. 1997) and in turn 
ApoE2 have an enhanced endogenous synthesis of cholesterol to 
compensate poor absorption. We speculate that the delay observed in 
treated mice could be related to interferences produced by BDE-209 on the 
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cholesterol endogenous production; however, further research is needed in 
order to corroborate these results and to explore possible mechanisms of 
action. In this study, endpoints such as thyroid function, myelination 
patterns or BDNF and TrkB levels are assessed at discrete points in the life 
cycle and it would be interesting to assess these endpoints at various points 
in time to characterize the temporal pattern of these measures. 
 
Body weight is also affected by the genotype and the BDE-209 treatment, 
and those factors interact with gender and age. ApoE4 mice showed lower 
body weight after weaning compared with other genotypes, although litter 
size in ApoE4 genotype was smaller. At a young age, ApoE4 females 
showed a markedly lower body weight and, although differences among 
genotypes shortened with age, a lower body weight remained in old ApoE4 
females. ApoE2 body weight gain was affected by BDE-209 exposure after 
weaning, but these effects disappeared in young and old adults. In contrast, 
BDE-209 effects in ApoE4 body weight were not observed during 
development but appeared in adults. ApoE4 young males exposed to BDE-
209 weighed significantly less and the treatment effect became evident 
with age in ApoE4 females. In general terms effects related to BDE-209 
observed in ApoE2 during development were no longer present in adults.  
 
General activity assessed in the EZM and the OF tests diminished with 
increasing age as expected, but it was clearly affected by the genotype in 
both young and old mice. ApoE4 was hypoactive compared to the other 
genotypes, while ApoE2 showed a similar exploratory behaviour to the 
ApoE3 in EZM, but an increased locomotor activity in the OF. It is worthy 
to note that the increased activity observed in the ApoE2 mice, throughout 
the different ages tested, was not observed in a previous study carried out 
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by Raber’s group that included ApoE2 mice. BDE-209 exposure affected 
the general activity at 4 months of age, depending on the genotype and sex. 
At a young age, the treatment increased activity in ApoE2 males, while 
decreased activity in ApoE3 and ApoE4 females, the latter being the most 
affected group. In aged mice, the effects of BDE-209 on activity disappear, 
likely because, indeed, the general activity was lower.   
 
Throughout life, ApoE3 mice showed the least anxious profile followed by 
ApoE2 mice. Instead, ApoE4 explored less the open areas (EZM) and the 
centre of the OF, and showed higher levels of freezing at 4 and 12 months 
of age. In aged female mice, BDE-209 increased anxiety levels in ApoE3 
genotype, equating their anxiety levels to those exhibited by the other 
groups. 
 
Spatial learning ability was clearly different among genotypes at both 
young and old ages. ApoE3 displayed the best acquisition performance in 
the MWM reference memory task followed by ApoE2 in young mice, 
while ApoE4 showed higher latencies throughout the training period. Aged 
female mice showed slight worsening in acquiring the task, compared to 
young mice, but all groups achieved good learning scores at the end of the 
training. ApoE3 and ApoE2 females showed comparable acquisition 
performance at 12 months of age, while ApoE4 females continued 
requiring higher time and longer distances to get the platform compared to 
their counterparts. No differences were found between males and females 
in spatial navigation at 4 months of age; however, the BDE-209 treatment 
effect was only evident in ApoE3 males at 4 months of age whose treated 
animals showed increased latency and distance travelled to reach the 
platform. These detrimental effects of BDE-209 also appeared in females 
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with age, indicating that BDE-209 effects increased with age after a 
postnatal exposure. Other authors have also been reported this in 
habituation patterns and operant behaviour (Rice et al., 2009; Viberg et al. 
2003) suggesting delayed toxicity. 
 
Retention was also different among genotypes. As expected, the best 
retention during the training period was shown in ApoE3, though all the 
genotypes improved over time and they showed similar retention at the end 
of the acquisition period. At 4 months of age, males outscored females in 
ApoE2 and ApoE4 groups, however sex differences were only statistically 
significant for control ApoE4 mice in the last probe trial. BDE-209 
treatment affected the retention only in young ApoE3 males; while this 
effect also appears in ApoE3 females with age. Aged ApoE3 females 
exposed to BDE-209 also showed poorer long-term memory.  
 
Some of the effects produced by postnatal exposure to BDE-209 are 
observed in groups showing good scores for learning or low scores for 
anxiety. The ApoE3 genotype is particularly more vulnerable to the effects 
induced by BDE-209 on learning and memory. Similar scores obtained in 
ApoE3 males and females and the low variability observed in this genotype 
can increase statistical power to find the differences between control and 
exposed animals. In the ApoE4 group, the worsening effects of the 
genotype are probably stronger than toxic exposure. There is a common 
limitation of behavioural testing, which is when base levels are too low 
(ground effect) or too high (ceiling effect), so external manipulations, 
including pharmacological approaches, are not able to show any effect. In 
our opinion, some of the lack of effects on activity levels in aged ApoE4 
mice could be related to this issue. At the same line, it is difficult to find 
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detrimental effects of the treatment in subjects whose learning baseline is 
poor. The different effects dependant on the genotype might ultimately 
mask the toxics effects in studies carried out in the human population when 
genotype differences are not taken into account. It is worthy of note that, 
according to the results obtained in this study, the vast majority of the 
population, who are ApoE3 carriers according to ApoE allele frequencies, 
would be at more risk of being affected by BDE-209 exposure. However, 
the effects will not be evident in epidemiological studies because the effect 
of BDE-209 is to diminish the ability of the ApoE3 genotype to the level of 
that observed in the other genotypes, which makes the population more 
uniform. 
 
This study has shown that the ApoE genotype plays an important role in 
behaviour and learning, not only in old ages but also in late development 
and young adulthood. Furthermore, the ApoE genotype determines 
different vulnerabilities to the toxicity produced by postnatal exposure to 
BDE-209, which affects different functional targets within each genotype 
and at different stages of life. Interestingly effects are mainly observed in 
those subjects (ApoE3) obtaining the better learning scores, normalizing 
the scores to those of mice from the other genotypes. Thus, this effect could 
pass absolutely imperceptibly in human populations. In general, some sex 
differences exist during development, such as body weight, activity levels, 
anxiety or learning and memory, but these differences are small. More 
interestingly, sex interacts with the genotype and the treatment, which 
shows that the effects of BDE-209 exposure are dependent on these factors. 
 
It is relevant to point that BDE-209 exposure during the postnatal period is 
able to affect development and to produce effects in adults, which last and 
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worsen with age. Furthermore, it should be highlighted that, despite the 
disruptive effects of BDE-209 not causing severe impairments, those 
effects are, however, triggered by a single exposure early in life and affect 
subjects with a distinct vulnerability in a different way. In the human 
population, those exposures may be responsible for subclinical deficits in 
children and adults and an increased or accelerated decline in the elderly. In 
addition, it should be taken into account that there are vast number of 
chemicals present in the environment that are able to trigger 
neurobehavioural derangements and may interact or add power to the 




Our results highlight the importance of studying genetic vulnerability to 
toxic agents and the use of longitudinal approaches for detecting the long-
lasting effects of toxic substances, but raise a number of issues for further 
studies. The scope for further research mainly concerns the areas of: 
1) Providing more face-validity to the exposure to BDE-209 compared 
to a human exposure,  
2) Further exploring the neurobehavioural effects observed,  
3) Aiming to elucidate the mechanisms through which BDE-209 acts. 
 
The following considerations offer some direction for the development of 
future research that will reinforce and extend the findings of this thesis. 
 
 In the current study, a single exposure to BDE-209 at a growth peak 
during development has caused long-term derangements. We 
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propose a longer period of exposure at lower doses, which would 
better mimic the continued exposure in human infants and would 
provide a wider period of development during which more critical 
events take place. 
 
 It would be also interesting to explore the hyperactivity found in 
ApoE2 females. As higher levels of anxiety did not accompany that 
greater activity, we suggest evaluating ApoE mice in a 5-choice 
serial reaction time task in order to assess attention deficits or 
impulsive behaviours, which are characteristic of ADHD. 
 
 In this study we have found differences among genotypes and effects 
of BDE-209 on learning and memory in the MWM task. We 
observed that, despite the worst acquisition being in the ApoE4 
group, their retention was good and the males of that group tended to 
increase learning in the later sessions, while other groups, and 
especially females, showed a ceiling effect. For this reason, it would 
be interesting to assess learning for longer periods to determine when 
asymptotic learning occurs for all the genotypes. Additionally, as we 
found higher levels of anxiety in ApoE4 mice, it would be useful to 
employ less stressful spatial tasks, such as the Barnes Maze. 
Furthermore, the evaluation of other types of learning, such as 
Contextual and Cued Fear Conditioning, would provide very 
valuable information. This task is able to discriminate learning 
impairments associated to amydala or dependant on the 
hippocampus, which is the aim of a study currently underway. 
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 Our findings showed that age is an important factor in determining 
the effects of early exposure to BDE-209, since some effects emerge 
punctually at certain life stages and the manifestation of other effects 
remain or worsen with age. Regarding this, and taking into account 
that cognitive deterioration was not observed in mice at 12 months of 
age, it would be of great interest to evaluate that at very advanced 
ages. In fact, we have a study in progress in which ApoE mice have 
been subject to postnatal exposure to BDE-209 and are being 
evaluated at 18 months of age. 
 
 The differences in thyroid hormone status found among genotypes, 
and the disruption in thyroid hormones observed after postnatal 
BDE-209 exposure make it interesting to better characterize the 
hormonal status by analysing TRH and TSH levels in order to detect 
the level at the hormonal axes interference.  
 
 Another study of interest is the determination of BDNF and TrkB 
levels in other brain structures such as the frontal cortex and at 
different time-points in the lifecycle. 
 
 The effects of exposure to BDE-209 on the myelin pattern are 
considered a key point of the study. Nevertheless, these results 
require corroboration by the use of semi-quantitative methods and a 
follow-up study at different stages of development.   
 
 Further on, it would be of interest to explore epigenetics as a 
mechanism for the effects observed on the myelin pattern by 
exposure to BDE-209, elucidating whether those effects observed are 
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a consequence of a direct action on MBP or other myelin-related 
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Chapter VI: Conclusions 
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1. ApoE4 mice showed a delay in neuromotor maturation and sexual 
maturation only in males.  
 
2. ApoE4 mice showed a lower body weight than the other ApoE 
genotypes from weaning to adulthood. 
 
3. ApoE4 mice are less active and more anxious than the other ApoE 
genotypes at 4 and 12 months of age.  
 
4. Spatial learning is different among ApoE transgenic mice at 4 
months of age. ApoE4 showed the worst acquisition of the task, 
ApoE3 showed the best acquisition performance and ApoE2 showed 
an intermediate learning phenotype. 
 
5. At 12 months of age ApoE4 performed worse in spatial learning 
than ApoE2 and ApoE3 mice.  
 
6. Adult ApoE2 mice showed lower levels of thyroid hormones, 
especially in T3 levels.  
 
7. BDNF levels in the hippocampus of adult ApoE2 mice are higher 
than those in ApoE4 mice. 
 
8. TrkB receptor levels in the hippocampus of ApoE transgenic mice 
differ among the three genotypes tested. The ApoE2 showed the 
highest levels and the ApoE3 showed the lowest levels.  
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9.  Postnatal exposure to BDE-209 produces a delay in physical and 
neuromotor development in ApoE2 mice.  
 
10. Postnatal exposure to BDE-209 produces long lasting effects on 
body weight in ApoE4 males at 4 months of age and ApoE4 females 
at 12 months of age.  
 
11. Postnatal exposure to BDE-209 decreases activity in ApoE4 
females at 4 months of age and increases anxiety in ApoE3 females 
at 12 months of age.  
 
12. Postnatal exposure to BDE-209 impairs spatial learning in ApoE3 
males at 4 months of age and long-term memory in ApoE3 females 
at 12 months of age.  
 
13. Effects of postnatal exposure to BDE-209 are observed in 
developing ApoE2 mice and in young adult ApoE4 mice. The most 
consistent effects across the lifespan are observed in ApoE3 mice 
and consist of impaired learning at 4 months of age, and impaired 
learning and memory and increased anxiety at 12 months of age.
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